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Abstract 
Recently a native endonuclease, purified from Rattus norvegicus liver, having the 
ability to cleave c-myc mRNA within the coding region, was identified as syntaxin 18. 
The objective of this research was to generate, purify and test recombinant R. norvegicus 
syntaxin 18 for endonucleolytic activity. To further investigate the role of syntaxin 18, 
homologs to R. norvegicus syntaxin 18 were selected for endonucleolytic testing: Mus 
musculus, Xenopus laevis, Drosophila melanogaster, Caenorhabditis elegans, 
Arabidopsis thaliana and Saccharomyces cerevisiae. The homologs, excluding C. 
elegans and S. cerevisiae, were expressed but not tested for endonucleolytic activity. 
R. norvegicus syntaxin 18 cDNA was amplified and subcloned into protein 
expression vector pET28a. E. coli BL21 were transformed with the modified vector and 
induced. Upon removal of the trans membrane domain, the recombinant protein was 
expressed, purified and tested for endonucleolytic activity against a portion of c-myc 
mRNA using an endonuclease assay. 
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CHAPTER 1 - Introduction 
Introduction 
The expression of genes governs numerous biological processes in living organisms. 
The majority of the genetic instructions are housed within the nucleus in polymers of 
nucleic acids, called DNA. As chromosomal DNA is restricted to the nucleus, gene 
expression is dependent upon mRNA transporting the instructions into the cytoplasm, 
where protein synthesis organelles, ribosomes, direct the expression of genes. In the 
biological cell, a means of regulating gene expression is necessary to ensure all metabolic 
functions run efficiently within the cell. Regulating gene expression has various control 
points targeting transcription, RNA processing, nuclear export, mRNA stability 
translation and finally post-translational degradation. A universal regulation point in 
biological systems is controlling mRNA cellular half-life. Gene silencing at the level of 
mRNA degradation, a post-transcriptional control, is of particular interest for gene 
therapeutics in the control of genetic diseases including cancer. The introduction will 
discuss mechanisms that direct enzymatic mRNA degradation in the cytosol. The focus 
of the introduction will be on mRNA degradation by endonucleolytic pathways, including 
substrate and sequence specificity of endonucleases. A discussion on catalytic domains 
of endonucleases and provide a brief overview of an array of eukaryotic endonucleases 
will be presented. A brief overview of exonucleolytic degradative pathway will be 
included for comparative purposes. 
In addition, an overview of the structure and function of syntaxin 18, will be provided 
as the focus of this research is to express, purify and test recombinant R. norvegicus 
syntaxin 18 for nucleolytic activity when challenged with a mRNA transcript (Bergstrom 
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et al. 2006). A previous research group tentatively identified native R. norvegicus 
syntaxin 18 as a novel endonuclease that cleaved a portion of the c-Myc mRNA in vitro. 
As the RNA substrate used for the endonucleolytic testing in this research is derived from 
the proto-oncogene c-Myc, background information on c-Myc will be reviewed. 
A second objective of this research is to see if any of the sequence homologs to R. 
norvegicus syntaxin 18 have endonucleolytic capabilities. If any are found to have 
endonucleolytic ability, then they could serve as model organisms in research development. 
1.1. mRNA Turnover in Eukaryotes 
Research has documented that mRNA turnover has three important roles in eukaryotic 
metabolism. First, mRNA degradation regulates duration of gene expression. Secondly, 
mRNA turnover is used as a quality assurance control by the cell to destroy mRNA 
transcripts that have a premature stop codon and thirdly, mRNA decay pathways have 
been identified as an antiviral defense mechanism (Dodson et al. 2002, Parker et al. 
2004). 
Researchers are in agreement that there are two general pathways of mRNA 
degradation. One pathway utilizes exonucleases that cleave consecutive nucleotides in a 
3'—>5' or 5'—>3' direction. The second pathway employs endonucleases that are either 
sequence or secondary structure specific (Staton et al. 2000, Dodson et al. 2002). 
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1.1.1. Deadenylation-dependent mRNA Degradation 
Within eukaryotes, mRNA decay often begins with the removal of the poly-adenylated 
tail at the 3' terminus of the transcript followed by exonucleolytic decay, 3'-5'. 
Deadenylation-dependent mRNA degradation requires the shortening of the poly (A) tail 
in a 3'-5' direction by the exosome. The exosome, first characterized in yeast, is a 
multiprotein complex often nucleases that is related to the bacterial degradosome 
(Alberts et al. 2002, Milligan et el 2005). Research has demonstrated that exonucleolytic 
function of the exosome is dependent upon the integrity of each of the core ten nucleases 
that make up the exosome (Milligan et al. 2005). A mutation in any one of the ten 
components of the complex resulted in a non-functioning exosome (Milligan et al. 2005). 
Once the poly (A) tail has been reduced to approximately thirty adenines, the degradation 
becomes rapid, with the generation of decay fragments in seconds (Staton 2000, Dodson 
et al. 2002, Brewer 2002, Parker et al. 2004). 
In the second deadenylation-dependent pathway, after shortening of the poly (A) tail 
to approximately thirty nucleotides, a decapping enzyme removes the protective 5'-7 
methyl guanosine cap there by exposing the transcript to exonucleolytic degradation in a 
5'—»3' direction. Studies in Saccharomyces cerevisiae have characterized the two 
distinct exonucleolytic pathways for mRNA degradation, which are conserved in all 
eukaryotes (Dodson et al. 2002, Parker et al. 2004). In the first exonucleolytic pathway, 
the exosome is responsible for deadenylation and degrades the mRNA in the 3'—*5' 
direction (Dodson et al. 2002, Parker et al. 2004). In the second pathway in S. cerevisiae, 
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after deadenylation by the exosome, the mRNA is decapped at the 5' end by the 
decapping enzyme Dcplp. After decapping, exonuclease Xrnlp continues transcript 
degradation in a 5'—>3' direction (Dodson et al. 2002, Parker et al. 2004). 
Deadenylation -dependent mRNA degradation is an important pathway in vertebrates 
as Xrnlp homologs have been described in other eukaryotes and is accepted as conserved 
pathways for mRNA degradation (Staton 2000, Dodson et al. 2002, Brewer 2002, Parker 
et al., 2004,). Exonucleolytic decay 5'—>3' following removal of the 5' cap has been 
demonstrated in mammalian c-fos and oat phytochrome A mRNA degradation pathways 
(Dodson et al. 2002). The 3'—•S'deadenylation-dependent pathway appears to be 
favoured over the deadenylation-independent decapping pathway, however further 
characterization of the exonucleolytic pathway is ongoing (Dodson et al., 2002). 
1.1.2. Deadenylation-independent decapping 
Deadenylation-independent decapping has been observed in Nonsense-Mediated 
Decay (NMD), believed to be a conserved pathway in eukaryotes as a means to maintain 
the integrity of gene expression. NMD appears to be an important pathway in mRNA 
containing a premature termination codon (Staton et al. 2000, Graham 2003). Following 
nuclear mRNA processing, an exon junction complex (EJC) is attached at the 3' end of 
the transcript and remains attached through a single round of translation; if the full 
mRNA is translated, the EJC is removed (Graham 2003). The function of the EJC is 
alleged to recruit the nonsense-mediated decay mechanism if the polysome reaches a 
premature termination codon (Graham 2003). First identified in S. cerevisiae, one 
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important enzyme in the NMD pathway is Upfl which binds mRNA and acts as a 5'—>3' 
ATP-dependent RNA helicase (Graham 2003). 
1.1.3. Endonucleolytic mRNA Degradation 
Endonucleases are present throughout the cell including the nucleus, cytosol, 
endoplasmic reticulum, polysomes, storage granules and processing bodies (Anderson et 
al. 2006). Endonucleases have preferred mRNA sequence specificity or structural motif 
recognition sites, cleaving within the body of the transcript. Once cleaved, the transcript 
fragments are exposed to exonucleolytic degradation where the 5' mRNA fragment is 
subjected to 3'—>5' exonucleolytic degradation while the 3' mRNA portion is subjected 
to 5'—*3>' exonucleolytic degradation (Tafech et al. 2006). 
Cz's-elements within the mRNA transcripts are cleavage sites for endonucleases. For 
instance, a cts-element of c-Myc mRNA known as coding region determinant (CRD) can 
be protected from endonucleolytic cleavage by the binding of proteins known as coding 
region determinant-binding proteins (CRD-BP). CRD-BP regulates the cellular half-life 
of the transcript by virtue of their association when bound to the cis-element. When the 
CRD-BP is removed, the cis-element is exposed and subjected to endonucleolytic 
cleavage followed by exonucleolytic degradation (Staton et al. 2000, Dodson et al. 2002). 
1.1.4. Endonuclease Catalytic Domains 
Endonucleases are ubiquitous in prokaryotes and eukaryotes, serving as nucleases 
with dual functionality as they structurally modify RNA precursors and aid in mRNA 
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degradation (Worrall et al. 2007). Current research into Esherichia coli endonuclease 
processing and degradation of RNA is providing insights into the mechanisms of 
endonucleolytic cleavage across all Kingdoms (Worrall et al. 2007). 
RNase H and RNase III are both elements of the RNA interference mechanism in 
eukaryotes, and also are found in prokaryotes. Each of these endonucleases requires two 
magnesium ions in their catalytic domains which assist in the nucleolytic attack and 
hydrolysis of the phosphodiester bond in the substrate. In the catalytic site of RNase H, 
one magnesium metal participates in the nucleophilic activation of water while the 
second magnesium stabilizes the transition state (Figure 1.1). 
Figure 1.1. RNase H depicting the catalytic domain (Nowotny et al. 2006). The lines 
represent the RNA strand of the RNA-DNA duplex. The ribbon structure is RNase H and 
the spheres are the magnesium ions within the catalytic domain. 
In RNase III one magnesium also assists in nucleolytic attack, however the second 
magnesium participates directly in bond hydrolysis (Figure 1.2). 
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Figure 1.2. RNase III catalytic domain (Gan et al. 2007). The ribbon structure is RNase 
III and the spheres (arrow pointing to) are the magnesium ions within the catalytic 
domain. 
The metal-ion participation in RNase III appears to be the more common pathway in 
metal-containing catalytic domains which are necessary components in a majority of 
endonucleases (Worrall et al. 2007). 
Research into RNase E is providing information about substrate target sites including 
rRNA and tRNA processing along with mRNA degradation in E. coll The catalytic 
domain of RNase E contains DNase I, RNase H and SI structural subdomains, all of 
which are found in a variety of RNA-binding proteins. The RNase E catalytic domain 
contains two magnesium-binding sites that are necessary for catalysis. RNase E is site 
specific and cleaves the single stranded mRNA by nucleolytic attack (Worrall et al. 
2007). 
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1.1.5. Compartmentalization of Endoribonucleases 
RNA granules are RNA-containing vesicles found in germ (germinal granules), 
somatic (processing bodies) and neuronal (neuronal granules) cells whose function 
includes mRNA storage, translation and degradation. RNA granules appear to be 
ubiquitous in eukaryotes (Anderson et al. 2006). 
Germinal granules function as storage units for mRNA required for embryonic 
development, while neuronal granules allow for protein synthesis at the synaptic 
membrane far away from the cell body. The processing body (P-body) contains 
exonucleolytic degradation enzymes, NMD mechanisms and RNA-induced silencing 
complex (RISC) along with translation proteins however the signaling and molecular 
pathways within the P-bodies are for the most part unknown (Anderson et al. 2006). 
1.2. Functional Conserved Pathways in Eukaryotes 
With the advancement of genomic sequencing, researchers have been working 
actively to identify functional and evolutionary patterns between closely and distantly 
related species. The comparisons of gene function are critical in understanding biological 
activities at the cellular level (Tatusov et al. 1997). Analysis of orthologous function in 
eukaryotes is providing insight into disease progression, which in turn can lead to 
therapeutic methods to halt disease progression. 
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Numerous eukaryotic orthologous groups have been extensively reviewed in 
functionally conserved pathways that are essential for survival such as cell adhesion, 
signaling, RNA processing, protein synthesis and vesicle trafficking (Rubin et al. 2000, 
Koonin et al. 2004, Bergmann et al. 2004). The importance of identifying orthologs in 
other eukaryotes to human genes, particularly those implicated in disease progression, 
cannot be under estimated. For example, identical metabolic processes in mammals 
allow alternative choices for researchers to explore both the positive and negative effects 
of new pharmaceuticals prior to human clinical trials. Furthermore, functionally 
conserved proteins in other organisms enable researchers to examine a metabolic 
pathway and pinpoint a regulation point in expression that could be targeted in 
therapeutic developments. 
Orthologs in S. cerevisiae, C. elegans and D. melanogaster are attractive to 
researchers because these organisms are not only easy to manipulate genetically but they 
are inexpensive and readily available. Furthermore these organisms have many proteins 
that have putative function to mammalian proteins. For example, many metabolic 
pathways that have been elucidated in S. cerevisiae have orthologs in mammals. For 
example, mammalian phosphorylation proteins that regulate the stability and activation of 
c-Myc are found is S. cerevisiae (Escamilla-Powers 2007). 
Upon sequencing the complete genome in Drosophila, proteomic analysis revealed a 
50% conserved function in mammalian metabolic pathways including cell cycle 
regulators, fluid/electrolyte transport across epithelia, hormone receptors and apoptosis 
(Rubin et al. 2000). Furthermore, 68% of mammalian oncogenes have had orthologs 
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identified in Drosophila, including proteins implicated in neurological diseases such as 
Alzheimer's, Parkinson's and Macular dystrophy (Rubin et al. 2000, Weinberg 2007). 
Unquestionably, the discovery of proteins with the similar function as in human not only 
provides proteomic knowledge, but provides a model organism for researchers to probe 
further into the intricacies of diseases with the ultimate goal of providing a cure for that 
disease. 
1.3. mRNA Stability in Eukaryotes 
Gene expression is facilitated by the nucleic acid, messenger RNA (mRNA) which is 
made up of nucleotides, each set of three making a codon, each corresponding to one of 
20 different amino acids. The mRNA codon sequence provides the blue print for 
proteins. Ribosomes in the cytoplasm are the translation machinery of mRNA. 
Ribosomes consist of two subunits, 20S and a larger 40S. The 20S subunit initiates 
translation by binding to the mRNA at the first AUG (start codon) in conjunction with 
tRNA followed by the association of the 40S subunit (Alberts et al. 2002). Numerous 
ribosomes can bind to the mRNA strand, all translating simultaneously, generating 
numerous polypeptide chains. (Alberts et al. 2002). Frequently proteins undergo post 
translational modifications before becoming functional. Glycosylation is the attachment 
of a carbohydrate chain, often seen in proteins that are destined for the cell membrane 
and is believed to enhance protein stability in the cellular environment (Petsko 2004). 
Phosphorylation and N-acetylation are reversible modifications that activate or inactivate 
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a protein (Petsko 2004). The cell has one means of controlling gene expression by mRNA 
cellular half-life. Half-life being the length of time it takes for half of the mRNA to be 
degraded in the cytoplasm. Cellular half-life is used as a measure of mRNA stability and 
an average cellular half-life is considered to be 10 hours (Alberts et al. 2002). The 
cellular half-life of mRNA is dependent upon mRNA stability signals that are 
incorporated in the mRNA post-transcription or involve the binding of protein elements 
protecting the mRNA from degradation (Audic et al. 2004). The mRNA of the globin 
protein family, which provides oxygen binding capabilities critical for erythroid cells to 
accumulate hemoglobin, has a relatively long cellular half-life. The stability of a and p-
globin mRNA, is estimated to be 24 - 60 hours and 16-20 hours respectively (Jiang et 
al. 2006). However, mRNA for cell-cycle related genes are tightly regulated, normally 
having cellular half-lives or thirty minutes or less. (Ross 1995, Alberts et al. 2002,). 
The stability of mRNA is influenced by cellular metabolic requirements necessary for 
physiological functioning of an organism and in response to environmental change 
(Audic et al. 2004). The regulation of mRNA stability is an important control step for 
determining cellular mRNA levels. 
When a tightly regulated gene's mRNA exists in the cytoplasm for an extended time, 
an increase in protein production occurs, often detrimental to the cell (Nigris et al. 2003, 
Audic et al. 2004). In the advanced stages of cancer, localized increase in tissue mass has 
been attributed to the stabilization of cell-cycle protein producing mRNA that normally 
has a cellular half-life of minutes now having a cellular half-life of hours (Audic et al. 
2004, Nigris et al. 2003). The oncogenes responsible for cancer progression are well 
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documented therefore one therapeutic challenge involves understanding the cellular 
control of mRNA degradation and effects on mRNA stability. 
1.3.1. Nuclear Modifications that Promote mRNA Cytoplasmic Stability. 
Prior to exiting the nucleus, eukaryotic mRNA is processed after transcription. Some 
post-transcriptional modifications are incorporated within the mRNA transcript to 
regulate mRNA cytoplasmic half-life. Nucleolytic degradation of mRNA in the 
cytoplasm is dependent upon cis-acting stability mRNA sequences, trans-acting protein 
factors and RNA-binding proteins (Staton et al. 2000, Brewer 2002, Dodson et al. 2002). 
Many mRNA transcripts have a 7-methyl guanosine nucleotide "cap" attached at the 
5' terminus and a polyadenine (poly(A)) tail of approximately 200 nucleotides in length. 
Both modifications increase the stability of the transcript (Staton et al. 2000, Alberts et al. 
2003). The 7-methyl guanosine cap (cap) appears to have two roles. First, the cap offers 
stability as the 5'-3' phosphodiester bond provides protection from wide-ranging 
exonucleases. Secondly, the cap acts as a point for translational control as the binding of 
the eukaryotic initiation factor 4E (eIF4E) protein, a subunit of a heterotrimeric complex, 
is required to recruit and initiate assembly of a ribosome onto the 5' end of the transcript 
(Dostie et al. 2000, Staton et al. 2000). An example of 5'control is the Iron-
responsive elements (IRE) located in the 5 '-UTR of ferritin mRNA bind with iron-
regulation proteins (IRP) blocking the binding of the ribosomal initiation complex 
therefore inhibiting translation (Staton et al. 2000). 
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1.3.2. Cytoplasmic mRNA Binding Protein Interactions 
RNA-protein interactions have an important role in regulating post-transcriptional 
gene expression. Eukaryote mRNA degradation is dependent upon specific cz's-acting 
stability-modifying elements and trans-acting protein factors (Staton et al. 2000, Dodson 
et al. 2002, Audic et al. 2004). Specific cz's-elements binding with trans-acting protein 
factors in the 3'untranslated region (3 '-UTR) aid in the stability of mRNA as seen in a 
and P-globin. C7s-elements in the coding region of mRNA bind trans-factors to regulate 
levels of protein expression with short-lived mRNA. The cis-elements appear to be the 
site for cleavage as interaction between c/s-elements and trans-acting proteins forms a 
complex that protects mRNA from degradation by preventing interaction with 
endonucleases (Staton et al. 2000, Dodson et al. 2002, Audic et al. 2004). If the coding 
region determinant is left unprotected, mRNA destabilization is promoted (Staton et al. 
2000, Audic et al. 2004). For example, in c-Fos mRNA, a cw-acting element, coding 
region instability determinant (CRD), binds with trans-acting proteins in the coding 
region and acts as a translational control. When the trans-acting factor is released from 
the CRD, rapid degradation of the transcript proceeds (Staton et al. 2000, Dodson et al. 
2002, Audic et al. 2004). c-Myc mRNA also has a CRD that is protected by a 
binding protein from cleavage and will be discussed in section 1.6.3. Research into these 
elements is determining that in some instances the release of a trans-factor from a cis-
element can be under hormonal and cellular stress control (Staton 2000, Dodson el al 
2002). 
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1.3.3. mRNA Instability AU-Rich Element (ARE) 
The AU-rich element (ARE) is an AUUUA pentamer located in the 3' untranslated 
region (3' UTR) (Stoecklin et al. 2001). The ARE was first characterized in mRNA of 
cytokines who have anywhere from two to nine AUUUA pentamers which facilitate the 
degradation of mRNA (Stoecklin et al. 2001). Along with the cytokines, AREs are also 
found in genes involved in cellular growth (Barreau et al. 2005, Audic et al. 2004, 
Stoecklin et al. 2001). AREs functioning as RNA destabilizing elements have been 
identified in numerous mRNAs of proto-oncogenes including c-fos, c-jun, c-myc and 
interlukein (Staton et al. 2000, Dodson et al. 2002, Audic et al. 2004). 
ARE regions can be protected from cleavage when bound to trans-factors, hence the 
mRNA is protected from degradation. A well characterized AU-rich element binding 
protein is the human homolog of the embryonic lethal abnormal visual gene (ELAV), a 
member of the RNA recognition motif superfamily, first characterized in Drosophila 
(Anitic et al. 1997). The human homolog of ELAV-RNA-binding, is HuR, a 36 kDa 
RNA-binding protein that binds to the ARE region of many mRNA transcripts such as 
vascular endothelial growth factor, c-fos, c-jun and interlukein 3 (Staton et al. 2000, 
Dodson et al. 2002, Cherradi et al. 2006). The characterization of HuR is still ongoing, 
however it is believed that HuR increases the stability of the transcripts by protecting the 
ARE from nucleolytic cleavage as the transcript travels from the nucleus into the 
cytoplasm (Staton et al. 2000, Dodson et al. 2002, Cherradi et al. 2006). 
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Another well known trans-factor is Poly (A) binding protein (PABP), a highly 
conserved 71 kDa protein that promotes stability by binding to either the poly (A) tail or 
to the AU rich sequences found in the 3' UTR preventing deadenylation (Ross 1995, 
Staton et al. 2000, Dodson et al. 2002). PABP also protects the 5'-7 methyl guanosine 
cap from degradation during translation by binding to the 5 '-7 methyl guanosine cap, 
creating a circular transcript (Staton et al. 2000, Dodson et al. 2002). 
1.4. Non-Substrate Specific Endonucleases across the Eukaryotes. 
Although endonucleolytic cleavage is not as well understood as exonucleolytic 
cleavage, recent research has begun to document and characterize eukaryotic 
endonucleolytic degradation of mRNA. A survey of various endonucleolytic pathways in 
the eukaryotes, specifically those species that are pertinent to this research follows. 
Focusing on these endoribonucleases may provide clues to the functional characterization 
of syntaxin 18 as an endoribonuclease. A known endonuclease that cleaves c-Myc RNA 
in its ARE region will be discussed in section 1.6.2. 
1.4.1. RNA interference (RNAi) 
RNA interference (RNAi) is an evolutionary conserved cellular response to the 
introduction of foreign double stranded RNA (dsRNA) first identified in C. elegans. It 
has since been characterized in invertebrates, vertebrates and plants (Lingel et al. 2004). 
RNAi response to dsRNA is believed to be an ancient defense mechanism protecting 
organisms against viral infection and mobile genetic elements (Lingel et al. 2004). 
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The process of RNAi is activated upon dsRNA entering the cell, where the dsRNA are 
cleaved into 21-23 nucleotide fragments by Dicer, an enzyme containing two RNase Ill-
like domains (Lingel et al. 2004, Liu et al. 2004). These nucleotide fragments, small 
interfering RNA duplexes (siRNA) are integrated into a protein complex, the RNA-
induced silencing complex (RISC). The siRNAs become a template to identify 
complimentary mRNA for degradation (Lingel et al. 2004). Researchers have identified 
the endonuclease within RISC as Argonaute2, a member of the protein family 
Argonautes (Figure 1.3). 
Figure 1.3. Argonaute2 catalytic domain (Rivas et al. 2005). The ribbon structure is 
Argonaute2 and the sphere is a magnesium ion within the catalytic domain. 
The presence of Argonautes has been detected in C. elegans, Drosophila, plants and 
mammals (Liu et al. 2004). The catalytic domain of Argonaute2, Piwi, is structurally 
similar to the catalytic domain of RNase H (Liu et al. 2004). 
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1.4.2. Irel endonuclease 
Researchers have discovered an unique mRNA signaling pathway in S. cerevisiae that 
links the unfolded protein response (UPR) in the endoplasmic reticulum (ER) with 
transcription in the nucleus using Irel, an ER transmembrane kinase with endonuclease 
domains, conserved in the eukaryotes (Figure 1.4) (Niwa et al. 2004, Zhao et al. 2006). 
Figure 1.4. Irel catalytic domain with RNA substrate (Lee et al. 2008). Endonuclease Irel 
represented by the ribbon structure, RNA substrate represented by the lines and the 
magnesium ions are the spheres (arrow pointing to). 
The UPR is initiated when Irel's amino-terminus detects unfolded proteins in the ER 
lumen. Upon detection of unfolded proteins, transcription activator Hac I mRNA is 
cleaved by Irel at two site-specific locations, removing an intron followed by ligation of 
the two exon ends (Niwa et al. 2004). Hac I expression is activated by the removal of the 
introns and Hac I transcription factors are synthesized then transported into the nucleus 
where the transcription factors promote induction of UPR target genes (Niwa et al. 2004). 
There is evidence that suggests Irel in mammals can engage other localized ER 
transcripts as Irel appears to have a range of sequence specificity (Dodson et al. 2002, 
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Hollien et al. 2006). The relevance of Irel to this research is that it is a ER membrane 
bound endoribonuclease and syntaxin 18 is also localized in the ER membrane. 
1.4.3. C. elegans RNase HI 
RNase H in prokaryotes and eukaryotes has been characterized as an endonuclease 
that specifically degrades the RNA in RNA-DNA hybrid complexes (Arudchandran et al. 
2002). RNase H was first characterized in calf thymus tissue and the protein has been 
recognized in the prokaryotes (Kowhica et al. 2005). In C. elegans, four RNase Hi-like 
genes have been identified, H(I, A-C), each of which have unique structural features at 
the protein level (Kochiwa et al. 2005, Arudchandran et al. 2002). Only RNase HI and 
RNase HIA proteins have been demonstrated in vitro to exhibit endonuclease activity, 
degrading the RNA in RNA-DNA hybrid complexes (Arudchandran et al. 2002, Kochiwa 
et al. 2005). 
The structural domains of RNase HI and RNase HIA are similar in that both have the 
RNase H catalytic domain at the carboxy terminus however RNase HI has a double 
stranded RNA (dsRNA) and a RNA-DNA hybrid binding domain (dsRHbd) at its amino-
terminus whereas RNase HIA does not (Arudchandran et al. 2002, Kochiwa et al. 2005). 
RNase HI requires two magnesium ions while RNase HIA requires one magnesium and 
one manganese ion as cofactors (Arudchandran et al. 2002, Kochiwa et al. 2005). The 
cleavage sites for both endonucleases appear to be sequence specific (Kochiwa et al. 
2005). 
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1.5. Substrate Specific Endoribonucleases 
1.5.1. Polysomal Ribonulcese-1 (PMR-1) Endonuclease 
Two examples of substrate specific endoribonucleases are from the vertebrates, the 
first being Polysomal ribonuclease^l (PMR-1), a 63 kDa endonuclease (Dodson et al. 
2002). Egg laying vertebrates require an enormous quantity of oocytes to ensure survival 
of a few offspring. To produce the eggs, large amounts of the egg yolk precursor 
vitellogenin are required, therefore stabilization of vitellogenin mRNA allows the 
production without more mRNA production (Dodson et al. 2002). Vitellogenin mRNA is 
stabilized by vigilin, a 3'-UTR-binding protein which itself is regulated by estrogen 
(Dodson et al. 2002). PMR-1 has been identified as the nuclease that preferentially 
cleaves vitellogenin mRNA when the 3'-UTR is exposed (Dodson et al. 2002). PMR-1 
endonucleolytic activity is induced by an increase in estrogen and has been shown to 
cleave albumin mRNA as well as vitellogenin mRNA and does not appear to cleave any 
other mRNA (Dodson et al. 2002). 
1.5.2. Erythroid Enriched (ErEN) Endonuclease 
The second example of a substrate specific endoribonuclease is erythroid enriched 
endonuclease, (ErEN). ErEN has been characterized as the endonuclease that specifically 
cleaves with the aid of other as yet identified proteins, a-globin in the globin's C-rich 
region in the 3 '-UTR (Rodgers et al. 2004). The C-rich region is protected from cleavage 
by the binding of trans-factor a-complex-poly(A)-binding protein (Rodgers et al. 2004). 
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ErEN has a novel requirement for an endonuclease as ErEN requires deadenylation of the 
poly(A) tail before it can cleave (Rodgers et al. 2004). The removal of the poly(A) tail 
facilitates the disruption of the a-complex-poly(A)-binding protein therefore exposing 
the specific site in the C-rich region for cleavage by ErEN (Rodgers et al. 2004). 
1.6. Proto-Oncogene c-Myc 
A target for substrate specific endonucleolytic cleavage of importance to this thesis is 
the proto-oncogene, c-Myc. The c-Myc proto-oncogene codes for transcription factor c-
Myc that is essential for metabolic cellular processes encompassing cell growth, 
proliferation, differentiation and apoptosis (Gregory et al. 2002, Li et al. 2003). 
Transcription factor c-Myc is a DNA-binding nuclear phosphoprotein that forms an 
obligate heterodimer with the protein Max (Myc associated protein x) (Schwab 2001). 
The heterodimer binds to an E-Box DNA sequence to initiate transcription (Kato et al. 
1992, Schorl et al. 2002, Gregory et al. 2003). c-Myc mRNA, with a normal cellular 
half-life of 18 minutes, has a localization signal which directs the mRNA to the 
perinuclear cytoskeleton for translation (Dubik et al. 1988, Dalgleish et al. 2001). 
Researchers speculate since the c-Myc protein has a cellular half-life in the range of 15 -
30 minutes, it is of utmost importance that the newly translated protein is directed rapidly 
into the nucleus (Hann 2006, Escamilla-Powers et al. 2007). Once in the nucleus, the c-
Myc protein is stabilized by phosphorylation on conserved residue serine 62 (Evans et al. 
2003, Gregory et al. 2003, Hann 2006, Escamilla-Powers et al. 2007). Phosphorylation 
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of conserved residue theronine 58 destabilizes c-Myc protein by changing its 
conformation, making the protein susceptible to degradation by a proteasome (Escamilla-
Powers et al. 2007). c-Myc is a highly conserved gene across all vertebrates and an 
orthologous D myc/Max complex has been identified in Drosophila (Kato el al 1992, Li 
et al. 2003). Should my thesis research reveal a syntaxin ortholog in Drosophila having 
endonucleolytic activity then Drosophila can be used as an inexpensive, readily 
manipulated model to elucidate further the characterization of c-Myc endonucleolytic 
degradation. 
Due to the important role that c-Myc has in cellular metabolic processes, it is strictly 
controlled at many levels including transcription, mRNA stability, translation and protein 
stability (Escamilla-Powers et al. 2007). The presence of multiple degradation pathways 
is realistic for a tightly regulated gene, particularly as alternate pathways then exist in the 
event that one pathway becomes non-functioning. 
Gene amplification is a common pathway for the increase of c-Myc mRNA. First 
characterized in poultry, researchers elucidated that the c-Myc gene could be incorporated 
into avian myelocytotomatosis virus genome thereby placing the c-Myc gene (v-myc) 
under the control of a retroviral transcription promoter creating a substantial increase in 
the amount of c-Myc mRNA (Weinberg 2007). c-Myc gene amplification was first 
recognized in human promyelocytic leukemia where the c-Myc gene was amplified 
approximately ten to 20 times per diploid genome (Weinberg 2007). Translocation 
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is another event that increases c-Myc mRNA levels. One of three highly active 
promoters from an immunoglobulin gene is translocated immediately upstream of the c-
Myc gene on chromosome 8 resulting in the over expression of c-Myc mRNA. 
(Weinberg 2007). 
The translation of c-Myc protein occurs through two pathways. The standard pathway 
is by cap-dependent scanning where the eIF4E cap-binding protein and other protein 
factors recruit the ribosome followed by scanning to the first AUG codon. A second 
pathway is initiated by internal ribosome entry where a complex RNA structural element 
(internal ribosome entry segment, IRES) downstream of the 5'7-methyl guanosine cap 
recruits a ribosome to bind. This second pathway is implicated in multiple myeloma, a 
C-T mutation in the DNA coding for the IRES causes a twenty-fold increase in c-Myc 
protein levels (Evans et al. 2003). As c-Myc is a notorious oncogene, control of c-Myc 
oncoprotein expression at any of its regulation points: transcription, mRNA stability, 
translation and protein levels would be a potential tool for battling cancer. 
1.6.1. c-Myc mRNA: Deadenylation-Dependent Degradation 
Brewer (2002) provided evidence for c-Myc mRNA degradation in vivo by rapid 
deadenylation-dependent degradation as previously described. In time sensitive 
metabolic pathways, expedited decay would be desirable as in those mRNA whose 
polypeptides are controlling cell division as over expression can be detrimental to the 
cell. Research has indicated that there are alternate pathways to c-Myc RNA degradation 
involving endonucleases. The two alternative c-Myc mRNA degradative pathways 
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engage endonucleases after the deactivation of protective specific binding proteins thus 
exposing particular sequences, targets for endonucleolytic cleavage (Lee et al. 1998, 
Brewer 2002, Rodgers et al. 2002). 
1.6.2. GAP-SH3-Binding Protein Complex Cleaves c-Myc 
RasGTPase-activating p_rotein (RasGAP) is characterized by its catalytic domain at its 
carboxy-terminus and &c homology 3 (SH3) domain at its amino-terminus. 
Phosphorylated RasGAP-SH3 forms a complex with RasGAPSH3-binding protein 
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(G3BP) (Gallouzi et al. 1998, Tourriere et al. 2001, Rodgers et al. 2002). G3BP has a 
RNA binding domain and when combined with RasGAP-SH3, RasGAP-SH3 
phosphorylates Ser-149 on G3BP. After phosphorylation, G3BP becomes activated 
exhibiting sequence/substrate specific cleavage of c-Myc mRNA (Gallouzi et al. 1998, 
Tourriere et al. 2001, Rodgers et al. 2002). The activated endonuclease complex moves 
into the nucleus where the 3'-UTR of c-Myc mRNA has a high affinity binding site for 
G3BP which preferentially cleaves c-Myc mRNA between CA dinucleotides (Tourriere 
etal. 2001). 
1.6.3. c-Myc mRNA: Endonucleolytic Degradation and the Coding Region 
Determinant 
Previous researchers identified a CRD-binding protein (CRD-BP) that appears to bind 
between nucleotides 1705 and 1886 within the CRD protecting the CRD region from 
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endonucleolytic attack (Lee et al 1998, Lemm et al. 2002, Bergstrom et al. 2006, Tafech 
et al. 2006). The binding of CRD-BP to the coding region instability determinant (CRD) 
in c-Myc mRNA has been shown in vitro (Sparanese et al. 2007). Within the coding 
region of c-Myc mRNA there is a purine-rich coding region determinant that interacts 
with a binding protein believed to protect the CRD from endonucleolytic cleavage 
(Tourriere et al. 2001). The CRD in c-Myc mRNA, located at the 3' end of the transcript 
appears to be the target of a second putatively identified endonuclease, syntaxin 18 
(Bergstrom et al. 2006) (Figure 1.5). 
5'-UTR Coding Region CRD 3'-UTR 
" ^ ^ M — A U ' — 
1705nt 1886nt 
Figure 1.5. Schematic of c-Myc mRNA illustrating the location and binding site of the 
CRD binding protein. The CRD site shown in dark grey, 1705 - 1886nt, is the target for 
endonucleolytic cleavage (Lee etal. 1998). 
The focus of this research is to determine if recombinant R. norvegicus syntaxin 18 is a 
novel endonuclease that cleaves c-Myc in vitro in the CRD region. This will be discussed 
in section 1.8. 
1.7. Syntaxin 18 the Putatively Identified Endoribonuclease 
A previous study, while purifying a polysomal c-Myc endonuclease from R. 
norvegicus liver, discovered a second, distinct endonuclease that was capable of cleaving 
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c-Myc mRNA within the CRD (Bergstrom et al. 2006). This novel 35 kDa endonuclease 
was distinct from the previously described polysomal c-Myc endonuclease (Lee et al. 
1998) as it was characterized as a magnesium independent, non-substrate specific 
endonuclease. This novel endonuclease was characterized as preferentially cleaving 
single stranded RNA between uracil/adenine, uracil/guanine and cytosine/adenine 
nucleotide sequences. Syntaxin 18 was identified as a tentative candidate for the novel 
endonuclease that cleaved c-Myc mRNA in the CRD region (Bergstrom et al. 2006). 
1.7.1. Syntaxin 18 - a Member of the t-SNARE Family 
Syntaxin 18 is a member of the soluble N-ethylmaleimide-sensitive factor (SNAP)-
attachment protein receptors (SNAREs). When two membranes approach, the SNAREs 
orchestrate the fusion of the vesicular membrane to the target membrane. SNAREs 
anchored in the vesicle membrane (v-SNAREs) interact with target membrane SNAREs 
(t-SNAREs). Currently 136 individual SNAREs have been characterized in eukaryotes, 
and of these 35 are SNAREs/syntaxins complexes that function in the 
endocytosis/exocytosis vesicle transport pathways (Teng et al. 2001, Hatsuzawa et al. 
2006). Syntaxin 18 (Figure 1.6), member of the syntaxin family, is anchored in the 
endoplasmic reticulum at its carboxy terminus; the amino-terminus is in the cytoplasm 
where syntaxin 18 assists in vesicular transport between the endoplasmic reticulum and 
the Golgi (Teng et al. 2001). 
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1.7.2. Vesicle Trafficking Between Endoplasmic Reticulum and Golgi 
Transport of cellular metabolic products between the ER and Golgi is essential for 
cellular function. The movement of vesicles between the ER and Golgi occurs in two 
directions. The transport of ER modified products to the Golgi (Ante retrograde) is one 
direction and the movement of Golgi vesicles back to the ER (retrograde) is the second 
direction. The movement of vesicles requires budding of vesicle from membranes and 
assimilation of the vesicle to receiving membrane. The fusion of the two membranes is 
not energetically favorable and repulsion forces must be overcome (Blank et al. 2001). 
The SNAREs facilitate the fusion between the two membranes through a harmonizing 
interaction between v-SNARE and t-SNARE (Blank et al. 2001, Alberts et al. 2002,). 
The docking of transport vesicles is mediated by the interaction of v-SNARE (members 
of the synaptobrevin family) and t-SNARE (members of syntaxin and SNAP-25 families) 
proteins. Syntaxin 18 has been identified as the member of the t-SNARE, principally 
located in the ER where it interacts with a v-SNARE protein, rSec22b during docking 
(Hatsuzawa et al. 2000). 
1.7.3. Structure and Function of Syntaxin 18 
A 17 amino acid trans-membrane domain anchors the carboxy-terminus of syntaxin 18 
in the ER membrane, while the balance of the protein and its amino-terminus is in the 
cytosol. Syntaxin 18 has a proximal SNARE coiled-coil domain approximately 60 
residues long, 32% of the protein (Figure 1.6) (Teng et al. 2001). 
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Figure 1.6. The predicted structure ofH. sapiens syntaxin 18. 
A. Predicted structure of syntaxin 18 using Protein Structure 
Prediction-Robetta Server (Kim et al. 2004). 
B. Linear representation of syntaxin 18 indicating SNARE domain. 
Syntaxin 18 aids in the docking between the ER membrane and the Golgi in the 
retrograde pathway by interacting with a v-SNARE protein, rSec22b. When the vesicle 
arrives at the ER membrane, Syntaxin 18 is activated by a calcium signal to become fully 
associated with its SNAP protein counterpart and rSec22b, generating a cis-complex 
initiated at the amino-terminus that forces the two membranes into close proximity which 
ultimately results in membrane fusion (Teng et al. 2001). The importance of the 
syntaxins in vesicle transport with respect to growth and development of mammals is not 
well known. It is speculated that syntaxins role in mammalian embryogenesis is vital and 
lack of syntaxin expression could be lethal suggesting other as yet characterized functions 
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of syntaxin 18 (Teng et al. 2001). A newly disclosed novel function of syntaxin 18 is its 
indirect role in phagocytosis (Hatsuzawa et al. 2006). 
1.8. Research Objective 
Syntaxin 18 is anchored in the endoplasmic reticulum where c-Myc mRNA is 
translated. Should recombinant R. norvegicus syntaxin 18 prove to have endonucleolytic 
capabilities, it is feasible that c-Myc mRNA is a readily obtainable substrate. As 
previously discussed, c-Myc mRNA is localized in the perinuclear cytoskeleton where 
translation occurs localizing c-Myc mRNA to an area of the cytoplasm where syntaxin 18 
could have access to the transcript. 
Syntaxin 18 is localized in the ER membrane as is Irel which indicates that 
endonucleases can be anchored in a membrane. If syntaxin 18 plays an indirect role in 
phagocytosis as a member of a vesicle membrane, then it is feasible that syntaxin 18 
could be a constituent of P-bodies where the contained mRNA is believed to be either 
degraded or silenced by the RNA-induced silencing complex (RISC) and therefore be 
involved in the degradation. The focus of the following research is to determine if 
recombinant R. norvegicus syntaxin 18 has endonucleolytic capabilities. At the same 
time, sequence homologs from other eukaryotes will be assessed for possible 
endonucleolytic activity, leading to the two following aims. 
Aim I of the research is to generate recombinant R. norvegicus syntaxin 18 protein for 
endonucleolytic testing. Positive results would confirm the identification of the novel 
native endonuclease purified from R. norvegicus liver. 
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Aim II of the research is to generate syntaxin 18 sequence homologs from other key 
eukaryotic model organisms to determine if endonucleolytic function is unique to R. 
norvegicus and mammals or is it a conserved function. 
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A bioinformatic analysis was prepared for syntaxin 18 putative proteins using data 
base computational tools against known sequence and structural domains. 
2.1. Search results 
Homologs to R. norvegicus syntaxin 18 were selected for analysis of putative proteins 
following a Basic Local Alignment Search Tool (BLAST) of the R. norvegicus syntaxin 
18 protein sequence (Atschul, 1997) against the protein databases in May 2005. The 
alignment identified a total of 120 sequence homologs with 37 species. Six individual 
species were selected from the list to focus on a wide range species from both closely and 
distantly related genes. Non-mammalian sequence homologs to syntaxin 18 were 
selected as well as mammalian since gene sequence can change over evolutionary time 
while gene function remains the same (Bergmann et al 2004, Tatusov et al 1997). A 
multiple sequence alignment using BLOSUM62 matrix with compositional matrix 
adjustment (Saunders et al 1991), was performed on the six sequence homologs and 
Homo sapiens syntaxin 18 against R. norvegicus syntaxin 18 to determine similarity 
between the seven species. All selected eukaryotic species are listed in Table 2.1. 
Table 2.1. Seven eukaryotic homologs with percent sequence alignment to 
R. norvegicus syntaxin 18. 
Species 
Homo sapiens 
Mus musculus 
Xenopus laevis 
Drosophila melanogaster 
Caenorhabditis elegans 
Arabidopsis thaliana 
Saccharomyces cerevisiae 
NCBI 
Accession # 
BT020135 
BC021362 
BC073006 
NM 0799761 
BJ785897 
BT002917 
L15081 
% Amino acid 
Sequence alignment 
93 
91 
77 
55 
45 
39 
Not significant 
E-Value 
2e-158 
le-157 
le-122 
5e-44 
le-13 
7e-25 
0.003 
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Interestingly, S. cerevisiae had no significant sequence alignment, e score 0.003 (Atschul 
1997) to R. norvegicus syntaxin 18 which indicates that possibly Ufe 1 gene is not a 
sequence homolog, even though Ufe 1 was putatively identified as SNARE fusion 
membrane protein (Hatsuzawa et al 2006). S. cerevisiae Ufe 1 appears to be similar only 
in the t-SNARE domain. 
2.2. Predicted Protein Size for each Gene 
Recombinant protein estimated molecular weights including the 6X His-tag were 
calculated (©EnCor Biotechnology) (Table 2.2): 
Table 2.2. Anticipated syntaxin/syntaxin-like recombinant protein 
size with the adc 
Species 
R. norvegicus 
H. sapiens 
M. musculus 
X. laevis 
D. melanogaster 
C. elegans 
A. thaliana 
S. cerevisiae 
ition of the 6X His-tag. 
Amino Acid 
Size 
334 
335 
334 
326 
395 
234 
310 
346 
Anticipated 
Size (kDa) 
40 
40 
38.5 
39 
47 
31 
37 
42 
A sequence alignment was generated for the mammals against R. norvegicus (Figure 
2.1) and the non-mammals (Figure 2.2) using Clustal W alignment server (Thompson et 
al, 1994). C. elegans was omitted from further analysis for reasons to be discussed in 
section 4.1.1. 
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Rat stx MAVDITLLFRASVKTVKTRNKALGVAVGGGADGSRDELFRRSPRPKGDFSSRAREVISHI 
Mouse stx MAVDITLLFRASVKTVKTRNKALGVAVGGGADGSRDELFRRSPRPKGDFSSRAREVISHI 
Human stx MAVDITLLFRVSVKTVKTRNKALGVAVGGGVDGSRDELFRRSPRPKGDFSSRAREVISHI 
********** ******************* ***************************** 
Rat stx GKLRDFLLEHRKEYINAYSHTMSEYGRMTDTERDQIDQDAQIFMRTCKDAIQQLRTEAHK 
Mouse stx GKLRDFLLEHRKEYINAYSHTMSDYGRMTDTERDQIDQDAQIFIRTCSEAIHQLRTEAHK 
Human stx GKLRDFLLEHRKDYINAYSHTMSEYGRMTDTERDQIDQDAQIFMRTCSEAIQQLRTEAHK 
************.**********.*******************.*** .** . ******** 
Rat stx EIHSQQVKEHRTAVLDFVEDYLKRVCKLYSEQRAIRVKRWDKKRLSKLEPEPHTKRKEP 
Mouse stx EIHSQQVKEHRTAVLDFVDDYLKRVCKLYSEQRAIRVKRVVDKKRLSKLEPEPHTKRKDS 
Human stx EIHSQQVKEHRTAVLDFIEDYLKRVCKLYSEQRAIRVKRVVDKKRLSKLEPEPNTKTRES 
***************** . .**********************************.** . . 
Rat stx AS-EKSSHNASQDSEEKPAAEDLPEKPLAESQPELGTWGDGKGEDELSPEEIQMFEQENQ 
Mouse stx TS-EKAPQNASQDSEGKPAAEELPEKPLAESQPELGTWGDGKGEDELSPEEIQMFEQENQ 
Human stx TSSEKVSQSPSKDSEENPATEERPEKILAETQPELGTWGDGKGEDELSPEEIQMFEQENQ 
.* ** . *.*** .**.*. *** ***.***************************** 
Rat stx RLIGEMNSLFDEVRQIEGKWEISRLQEIFTEKVLQQETEIDSIHQLWGATENIKEGNE 
Mouse stx RLIGEMNSLFDEVRQIEGKWEISRLQEIFTEKVLQQETEIDSIHQLWGATENIKEGNE 
Human stx RLIGEMNSLFDEVRQIEGRWEISRLQEIFTEKVLQQEAEIDSIHQLWGATENIKEGNE 
it*****************-*******************:********************* 
Rat stx DIREAIKNNAGFRVWILFFLVMCSFSLLFLDWYDS 334 
Mouse stx DIREAIKNNAGFRVWILFFLVMCSFSLLFLDWYDS 334 
Human stx DIREAIKNNAGFRVWILFFLVMCSFSLLFLDWYDS 335 
*********************************** 
Figure 2.1. CLUSTAL W 2.0.5 multiple amino acid sequence alignment of M. musculus, 
H. sapiens syntaxin 18 against R. norvegicus syntaxin 18. 
Symbol meaning: * - identical, : - similar amino acid functional type, . - similar amino 
acid. The dashes, — indicate gaps in the amino acid alignment. Bold indicates the 
predicted t-SNARE domain. 
The amino acid alignment of M musculus and H. sapiens to R. norvegicus further 
illustrates the extensive similarity of the protein sequences to R. norvegicus (Figure 2.1). 
The alignment of X. laevis, D. melanogaster, to R. norvegicus syntaxin 18 displays 
considerable similarity in both the amino/carboxy terminus and t-SNARE domain though 
D. melanogaster has a large insertion between amino acids 217 - 283 (Figure 2.2). A. 
thaliana has the largest predicted t-SNARE domain encompassing much of the protein 
(Figure 2.2). 
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Rat stx MAVDITLLFRASVKTVKTRNKALGVAVGGGADGSRDELFRRSPRPKGDFSSRAREVI 
Xenopus PRVRPRVRTLLFRASVKTVKTRNKALGVSLP ESDVLRRS-RPRGEFSGKAREVI 
Drosophila MDITQSFKASVMTVRLQRKAELAGKAKP ATVPTKTGPIGPKDDFAKQAKEVC 
Arabidopsis -MSRFRDRTEDFKDSVRNSAVSIGYNESKVAST----MASFIIHKPKERSPFTKAAFKTL 
Yeast MMSDLTPIFRKYVAVIDDARNEQNGIDDHVERKQE-DFGNSNETCEMFRDSFIKECARLL 
Rat stx SHIGKLRDFLLEHRKEYINAYSHTMSEYGRMTDTERDQIDQDAQIFMRTCKDAIQQLRTE 
Xenopus TNIGKLKDFLLEHRKDYINACSYVASEYSCMTDTERDQIDQDAQIFMRTCSDAIHLLRTE 
Drosophila NKITSLRNVLIENRTAYMRIGQHLKSAA-HMTDAQRDLIDRESEKFVTFYTQHLAKMRSD 
Arabidopsis DSIKELELFMLKHRKDYVDLHR TTEQEKDSIEQEVAAFIKACKEQIDILINS 
Yeast KFLVELNKVIKQIEKNYLDDFN MSDAEKDEFDMECRLQIQQYFKKFEFLENY 
Rat stx AHKE-IHSQQVKEHRTAVLDFVEDYLKRVCKLYSEQRAIR VKRWDKKRLSKLEPEP 
Xenopus AGKE-SHSVQIKEHRNAVLDFIEDYLKRVCKLYSEQRAIR VKRTVDKKRLTRLEPEK 
Drosophila WKSA-KRKPQERQHIDAVLDLLVSYLHSVEQIYLDQKKYR VQHELETYRLLKLAADK 
Arabidopsis IRNEEANSKGWLGLPADNFNADSIAHKHGWLILSEKLHS VTAQFDQLRATRFQ-DI 
Yeast EMERHNLSLKRFQSKSHRWSKILSNKNDNTKHVIHPQDIENGVYEFRLGVLRCLNLWIKY 
Rat stx HTKRKEPASEKS SHNASQDSEEKPAAEDLPEKPLAESQPELGTWGDGKG 
Xenopus INKTRTSHSVDS IPLKPLDTAD DESIDKTAPQRNGTSSLWDDGRS 
Drosophila KKIPVRPAGSNSGKLGRRQ VSNDDSEATKSSSQANGNHDESADNDWNNDAWGDWDE 
Arabidopsis INRAMPRRKPKR VIKEATPINTTLGNSESIEPDEIQAQPRR 
Yeast VSSKFTTIQQERLILENKMNFNSTPMPTLSNNADDFSADAIDISVSQSAPVETVQDEVKH 
Rat Stx EDE 
Xenopus EDE 217 
Drosophila DEEGDEVDDHDGEKGKEANQANQHKPRTRKRSKANRSDLNNSSSKMALDEELQQQQEADD 2 83 
Arabidopsis 
Yeast YEETIS 
Rat stx LSPEEIQMFEQENQRLIGEMNSLFDEVRQIEGKVVEISRLQEIFTEKVLQQETEIDS 
Xenopus LSPEEIQMFEQENQRLVSEMNSLFDEVRQIEGKVVEISRLQEIFTEKVLQQETEIDN 
Drosophila DDPLSAEDVQLFEAENVHIYNFLQGVSEEVEQIEKNWDIAQLQDIFTEKVAMQQHNIDR 
Arabi dopsis LQQQQLLDDETQALQVELSNLLDGARQTETKMVEMSALNHLMATHVLQQAQQIEF 
Yeast —KLTQEQLQVLETEHSELLNQKNEQLKKVETINKTILDIVNIQNELSNHLTVQSQNINL 
Rat stx IHQLWGATENIKEGNEDIREAIKNNAGFRVWILFFLVMCSFSLLFLDWYDS 
Xenopus IHELWGATENIKEGNEDIREAIKNNAGFRVWILFFLVMCSFSLLFLDWYDS 
Drosophila IVSAVVGTTENVKDANEQIRQATQRNAGLRVWSLFFLLVMSFSLLFLDWYYD 
Arabidopsis LYDQAVEATKNVELGNKELSQAIQRNSSSRTFLLLFFFVLTFSVLFLDWYS-
Yeast MLNNQDDIELNIKKGNKELRKAKRAAGRTAKMTTYGAIIMGVFILFLDYVG-
Figure 2.2. CLUSTAL W 2.0.5 multiple amino acid sequence alignment of X. laevis, D. 
melanogaster, A. thaliana, S. cerevisiae syntaxin homologs against R. norvegicus syntaxin 18. 
Symbols: * - identical aa,: - similar aa function type,. - similar aa, ~ gaps in aa alignment. 
Bold indicates predicted t-SNARE domain. 
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S. cerevisiae t-SNARE domain is similarly located at the carboxy terminus (Figure 2.2). 
2.3. Predicted Functional Domains 
A bioinformatic functional analysis was undertaken to examine any predicted 
functional classifications of the proteins that could have relevance to endonucleolytic 
activity. The probable homologous sequences were submitted to the SVM-Prot Server 
(Cai et al, 2003) (Table 2.3). The SVMProt Server's protein function classification 
accuracy is between 69.1-99.6% (Cai et al, 2003). 
Table 2.3. Functional protein prediction of the six homologs to 
R. norvegicus syntaxin 18 using SVM-Prot server. 
Species 
R. norvegicus 
H. sapiens 
M. musculus 
X. laevis 
D. melanogaster 
S. cerevisiae 
A. thaliana 
Nuc 
Presence 
Yes 
Yes 
Yes 
no 
no 
no 
Yes 
eic Acid Binding 
Type 
mRNA 
mRNA 
mRNA 
n/a 
n/a 
n/a 
DNA 
%P-value 
62.2 
62.2 
58.6 
n/a 
n/a 
n/a 
73.8 
Carbon -oxygen lyases 
Presence 
Yes 
Yes 
Yes 
Yes 
no 
no 
no 
%P-value 
58.6 
58.6 
58.6 
62.2 
n/a 
n/a 
n/a 
SVM-Prot predicted R. norvegicus, H. sapiens, and M. musculus syntaxin 18 to have a 
high probability of mRNA-binding function. Having the ability to bind mRNA would be 
an important first step in the ability for a protein to cleave mRNA. A. thaliana protein 
has a high probability of being a DNA-binding protein (Table 2.3). 
The putative proteins of the four vertebrates have a greater than 50% probability of a 
carbon-oxygen lyase domain (Table 2.3). This is significant as lyases are a group of 
enzymes that commonly add groups to double bonds or form double bonds by removal of 
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groups (Nelson 2003). As carbon-oxygen lyase will create or disrupt a double bond with 
carbon/oxygen, having a predicted functional domain could possibly force the function in 
a novel manner when the carbon-oxygen lyase containing protein is challenged by a RNA 
substrate that binds to in-vitro. 
All seven species have both a predicted asparagine glycosylation site and a myristyl 
motif (Yan et al 2005) which would be expected as t-SNARES regulate intra cellular 
vesicular traffic via membrane fusion events (Steegmaier et al 1998, Weimbs et al 1997). 
Post-translational asparagine glycosylation functions as a protein-protein recognition site, 
required for trafficking of membrane proteins. The myristyl motif controls protein traffic 
through the intra cellular membrane (Petsko 2004). 
Each of the seven species proteins has potential phosphorylation sites for both protein 
kinase and casein kinase II; the vertebrates and Drosophila have a third phosphorylation 
site for cAMP (Yan et al 2005). Phosphorylation of a protein can act as an on/off switch 
for an enzyme function, modifying the activity of a protein or create a new recognition 
site for a protein to bind (Petsko 2004). The seven species' syntaxin sequence homologs 
have not currently been identified as being enzymes. However, should an alternative 
phosphorylation site on the protein, distinct from those phosphorylation sites currently 
required for the protein to function in vesicle trafficking become phosphorylated, 
potential is there for a novel function. 
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2.4. Structural Similarity Analysis. 
All seven protein sequences were submitted to the NCBI Conserved Domain Search 
(Marchler-Bauer et al 2004) for structural similarity analysis, threshold E value 0.01. H. 
sapiens syntaxin 18 included for comparative purposes only. R. norvegicus, H. sapiens, 
and M. musculus syntaxin proteins have in the vicinity of their carboxy-terminus a zinc-
ribbon domain whereas A. thaliana has no such domain (Table 2.4). 
Table 2.4. Results of conserved domain search within the amino acid 
sequence of the syntaxin 18/syntaxin-like recombinant protein, 
n/a indicates no domain was found. 
Species 
R. norvegicus 
H. Sapiens 
M. musculus 
X. laevis 
D. melanogaster 
A. thaliana 
S. cerevisiae 
Zinc-binding 
Domain 
location 
229-288aa 
230-284aa 
229-288aa 
n/a 
n/a 
n/a 
n/a 
% Alignment 
to Zinc-ribbon 
33.1 
33.1 
31.4 
n/a 
n/a 
n/a 
n/a 
t-SNARE 
domain 
237-322aa 
238-323aa 
237-322aa 
229-314aa 
271-330aa 
56-306aa 
250-317aa 
% alignment 
t-SNARE 
32.5% 
32.5% 
32.5% 
32.5% 
42.4% 
84.5% 
100% 
Trans-
Membrane 
Domain 
location 
312-327aa 
313-328aa 
313-328aa 
304-319aa 
374-389aa 
290-304aa 
160-168aa 
The protein sequences were submitted to "DAS" - Transmembrane Prediction server 
(Cserzo et al, 1999) where all of the proteins have a trans-membrane domain at their 
carboxy terminus (Table 2.4). 
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A. 
B. 
C. 
• • 1 
229 • 228 334 
• • 
230-284 355 
^^ H 
229 • 288 m 
Figure 2.3. Schematic of zinc binding domain 
A. R. norvegicus, B. H. sapiens and C. M. musculus 
The zinc-ribbon domain is implicated with mRNA binding (Marchler-Bauer et al 
2004), which reinforces the mRNA-binding domain predicted by SVMProt (Cai et al 
2003). This domain is of significance for the role as an endonuclease as one would 
expect that a protein having the ability to bind would be the first step in cleavage of a 
substrate. Although the SVM-Prot Server predicted that A. thaliana has a DNA binding 
site, structural analysis of A. thaliana protein using NCBI Conserved Domain Server 
specified no DNA-binding domain. 
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3.1. Selection of Homologous Genes, Potential Orthologs to H. sapiens 
Syntaxin 18 
Selection of specific genes began with a National Centre for Biotechnology 
Information (NCBI) Basic Local Alignment Search Tool (BLAST) (Altschul 1997) in 
2005 against the protein sequence of R. norvegicus Syntaxin 18 (NCBI accession 
AB028741). From the identified genes, representatives from different species were 
chosen (Table 3.1). 
The selected gene containing source plasmids for the seven species (Table 3.1) were 
prepared for large scale amplification by initially transforming Escherichia coli, (E. coli), 
DH5a cells with the respective source plasmid (Table 3.1), followed by single colony 
selection for plasmid preparation. The harvested source plasmids were confirmed to be 
that of the original plasmid by restriction enzyme digest and DNA sequencing 
(MACROGEN). 
3.1.1. Preparation of Heat Competent Escherichia coli DH5a. 
E. coli cells (Novagen, Canada) were grown in 50 mL of Luria Broth (LB) (App. 2) at 
37°C with agitation until optical density at 600 nm (ODeoo) was between 0.4 and 0.5. The 
E. coli cells were pelleted by centrifugation at 2500 rpm, 4°C for five minutes. The 
pelleted cells were resuspended in 25 mL ice-cold 50 mM CaCb (Sigma), and incubated 
on ice for twenty minutes. After a second centrifugation under the same conditions, the 
cell pellet was resuspended in 3 mL ice-cold 50 mM CaCi2. 
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3.1.2. Heat-Shock Transformation of E. co//DH5a 
A 100 uL aliquot of the heat competent DH5a cells was pipetted into a 15 mL Nalgene 
test tube; 50 ng of cDNA source plasmids (Table 3.1) was mixed with the heat-
competent cells; the mixture was incubated on ice for 20 minutes then heat shocked in a 
42°C water bath with gentle agitation for two minutes. One milliliter of LB was added to 
the transformed DH5a cells immediately prior to incubation at 37°C, with agitation for 
45 minutes. LB agar plates with appropriate antibiotic selection, where streaked with 50 
(LiL of the transformed cells and incubated overnight at 37°C. Single colonies were 
selected and grown in 3 mL LB, antibiotic selected broth at 37°C overnight with agitation 
as a preliminary culture for large scale plasmid purification. 
3.1.3. Purification of Plasmid cDNA for all Seven Species 
Fifty milliliters of LB with antibiotic selection was inoculated with 50 uL of the 
overnight preliminary DH5a culture. The culture was incubated at 37°C, with agitation 
overnight. The DH5a cells were harvested after centrifugation at 6000g, 4°C for 15 
minutes. The gene containing plasmid was purified from the cells using Qiagen® Plasmid 
Midi Kit protocol (Qiagen, Canada). The cell pellet was resuspended in 4 mL of the 
resuspension buffer (App. 2) followed by a 4 mL volume of lysis buffer (App. 2). 
The cell buffer mixture was mixed with vigourous shaking. After incubating the cells 
for 5 minutes at room temperature, the lysis solution was neutralized with the addition of 
4 mL of neutralization buffer (App. 2) followed by a 15 minute incubation on ice. Cell 
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debris was pelleted by centrifugation at 20,000 g, 4°C for 30 minutes. The cleared 
supernatant was transferred to a clean Nalgene tube and the centrifugation step was 
repeated. 
A QIAGEN-tip 100 was equilibrated with 4 mL equilibration buffer (App. 2); 
supernatant from the second centrifugation step was loaded into the QIAGEN-tip 100 and 
allowed to flow through via gravity. The QIAGEN-tip 100 resin was rinsed twice with 
10 mL of wash buffer (App. 2). The plasmid DNA was eluted with 5 mL of elution buffer 
(App. 2). The plasmid DNA was precipitated out of solution with 3.5 mL isopropanol. 
The solution was centrifuged immediately at 15,000g, 4°C for 30 minutes. The pellet 
was washed with 70% ethanol followed by centrifugation at 15,000g, 4°C for ten 
minutes. The plasmid DNA pellet was air dried for five minutes then resuspended in 200 
uL MilliQ (Milli-Q Synthesis A10, Millipore, USA) water, pH 7.4. 
3.1.4. Primer Design for PCR to Incorporate New Restriction Sites 
Custom primers were designed using Invitrogen OligoPerfect designer® (USA) for 
each species with restriction enzyme sites incorporated at the 5' end. Forward primers 
incorporated a Ndel restriction site; reverse primers for R. norvegicus, M. musculus and 
X. laevis incorporated a Sad restriction site (Table 3.2). D. melanogaster, C. elegans, A. 
thaliana and S. cerevisiae reverse primers incorporated a Bam HI restriction site (Table 
3.2). Upon arrival from Invitrogen, the primers were resuspended in 200 uL of TE 
buffer, pH 7.4 (App. 2). The resuspended primers were quantified using an UV-
Spectrophotometer (Ultrospec® 1000, Biochrom) and final concentrations were 
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determined at 260 nm using the calculation in preparation for Polymerase Chain Reaction 
(PCR). 
MS 
oligo concentration (ug/uL) — (OD) x (— ) from certificate of analysis x 200 (Eqn 1) 
OD 
Table 3.2. Custom primers designed for R. Norvegicus, M. musculus, Xenopus, 
Drosophila, C. elegans, Arabidopsis and S. cerevisiae using Invitrogen 
OligoPerfect designer®. Bold indicates restriction enzyme (RE) site, 
identified in third column. 
Rat Fwd 
Rat Rev 
Mouse Fwd 
Mouse Rev 
Xenopus Fwd 
Xenopus Rev 
Drosophila Fwd 
Drosophila Rev 
C. elegans Fwd 
C. elegans Rev 
Arabidopsis Fwd 
Arabidopsis Rev 
Yeast Fwd 
Yeast Rev 
5' CGATATATCATATGGCGGTGGACATCACACTGCTCT 3' 
5' ATCGACGAGCTCATGGCTGTAATTGCGTTTATTAGC 3' 
5' AAAAAACATATGATGGCGGTGGACATCAGA 3' 
5' AGAGCTCCTAGCTGTCGTACCAGTCGAGG 3' 
5' CGATATATCATATGTGCTGAGGAGGAGCCGGCCGA 3' 
5' ATCGACGAGCTCAACGAGGTATTTATTAATGTACATCAG 3' 
5' CGATATATCATATGGACATCACCCAGAGCTTCAAG 3' 
5' AACGACGGATCCAATTTGGGGACTTCACTTAATCG 3' 
5' CGATATCATATGAAACAAGACCAGACTGAACAT 3' 
5' ATCGACGGATCCGATTCAAGCAAAGCACCCATG 3' 
5' CGATATATCATATGTCGAGATTCAGAGACAGGACG 3' 
5' ATCGACGGATCCTTAACTGTACCAATCCAAGAA 3' 
5' CGATATATCATATGATGTCTGATTTAACACCAATA 3' 
5' ATCGACGGATCCAGTGATATTAACCTACATAAT 3' 
Ndel 
Sad 
Ndel 
SacI 
Ndel 
SacI 
Ndel 
BamHI 
Ndel 
BamHI 
Ndel 
BamHI 
Ndel 
BamHI 
3.1.5. Expression Vectors Used in this Research 
Two protein expression plasmids were used in this research (Table 3.3). Plasmid maps 
are in Appendix 1. 
Table 3.3. Protein Expression Vectors 
Vector 
pHTT7K 
pET28a 
Size (Bp) 
5207 
5369 
Antibiotic 
Selection 
Kanamycin 
Kanamycin 
Source 
Sidney Altman 
Yale University 
Novagen Inc. 
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Each vector utilized the T7 promoter system and had a six histidine affinity tag 
incorporated down stream from the T7 promoter at the amino terminus. The 6X-His tag 
was utilized during protein purification procedures. 
3.1.6. Polymerase Chain Reaction (PCR) Procedure for Cloning 
The gene cDNA from the seven species (Table 3.1) was subjected to PCR to amplify 
the gene and to add restriction enzyme sites for manipulation (Table 3.2). The cDNA 
was amplified with the designed primers (Table 3.2) using PCR. A typical PCR reaction 
mix contained 2 ng template DNA, 100 ng forward primer, 100 ng reverse primer in a 
PCR mix containing 2.5 mM dNTPs, IX PCR buffer (App. 2) and 1 Unit of Taq 
polymerase (New England Biolabs). The 100 uL microcentrifuge tubes were loaded into 
a minicycler™ (MJ Research), with cycling parameters in Table 3.4. 
Table 3.4. PCR cycle used for amplification 
STEP 
1 
2 
3 
4 
5 
TEMP 
94°C 
50°C 
72°C 
4°C 
TIME 
30 sec 
30 sec 
45 sec 
29 times to 1 
Forever 
The PCR products had DNA loading dye added to a final 2% concentration and were 
electrophoresed on a 100 mL 1% agarose gel with 0.01 mg/mL ethidium bromide (EtBr) 
in a IX TBE running buffer at 32 mA, constant current until the dye front was two-thirds 
down the gel in preparation for gel purification prior to ligation into the expression 
vector. 
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3.1.7. Gel Purification of PCR Products and Expression Vector 
Amplified copies of the copy DNA and linearized vectors were purified from agarose 
gels using QIAEX® II Gel Extraction Kit (QIAGEN). A summary of the protocol from 
the QIAEX® II handbook follows. 
The DNA, after identifying the band, was sliced from the 1% agarose gel with a sterile 
scalpel and placed into a microcentrifuge tube. To the gel slice, 1 mL of Buffer QX1 and 
20 uL of QIAEX II were added. The slice with the reagents was incubated in a 50°C 
water bath for ten minutes, vortexing every two minutes to aid DNA binding to the 
QIAEX II suspension reagent. The mixture was centrifuged at 13,000 rpm for 30 sec; the 
supernatant discarded. The QIAEX II - DNA pellet was resuspended in 500 uL of 
Buffer QX1 followed by a 30 second centrifugation at 13,000 rpm. The supernatant was 
discarded; the DNA-containing pellet was resuspended in 500 uL of Buffer PE, 
centrifuged at 13,000 rpm for 30 seconds; supernatant discarded. The DNA-containing 
pellet was resuspended for a second time in 500 uL of Buffer PE followed by 
centrifugation. 
The DNA-containing pellet was air dried for 10 minutes before eluting the DNA with 
20 uL of MilliQ (Milli-Q Synthesis A10, Millipore) H20, pH 7.4. Elution time was five 
minutes followed by a 30 second centrifugation at 13,000 rpm. The supernatant was 
collected in a new microcentrifuge tube and quantified using a ND-1000 UV 
spectrophotometer (Nanodrop). 
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3.1.8. Restriction Endonuclease Digest of PCR Products and Expression Vector 
As a prepatory step for ligation, the PCR products and expression vector required 
digestion by specific restriction endonucleases. Restriction endonuclease digests of both 
amplified cDNA and expression vector were performed using the protocol that follows. 
R. norvegicus, M. musculus and Xenopus were digested with restriction endonuclease 
Ndel (New England Biolabs, USA) and Sad (New England Biolabs) (Table 3.5). 
Drosophila, C. elegans, S. cerevisiae and Arabidopsis were digested with restriction 
endonucleases Ndel and Bam HI (Invitrogen) (Table 3.5). The expression vector was 
digested using identical restriction endonucleases to the cDNA that was to be inserted. 
To ensure optimal enzyme activity, the glycerol concentration was kept at or below 
5% by increasing the final reaction volume and adjusting restriction enzyme buffer to 
maintain buffer concentration. The PCR products and expression vector were digested in 
separate microcentrifuge tubes. All digests were double digests incubated at 37°C for 1.5 
hours. 
Table 3.5. Restriction digest reaction mix 
Reagent 
PCR product 
or expression vector 
RE1 
RE2 
NEBuffer 4 
Bovine Serum Albumin 
(New England Biolabs) 
dH20 
Rattus, Mus, 
Xenopus 
1.0- 2.0 ug 
Ndel - 10 U 
S a d - 1 0 U 
IX dilution 
0.1 ug/uL 
Up to 20 uL 
Drosophila, C. elegans, 
Arabidopsis, S. cerevisiae 
1.0-2.0 ug 
Ndel - 10 U 
BamHI - 10 U 
IX dilution 
N/A 
Up to 20 |iL 
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Ethanol precipitation immediately followed the digest. An equal volume of 100% 
ethanol along with 1/10 volume of 3 M sodium acetate was added to the reaction. The 
mix was kept at -20°C for 20 minutes then centrifuged at 13,000 rpm at 4°C for 10 
minutes. 
The supernatant was discarded, the pellet washed with cold 70% ethanol, centrifuged at 
13,000 rpm for 2 minutes; supernatant discarded. The DNA pellet was air dried for 10 
minutes then resuspended in 20 uL MilliQ H20 at pH 7.4 and quantified on a ND-1000 
UV spectrophotometer. 
3.1.9. Sub-cloning cDNA into Expression Vector pHTT7K or pET28a Using 
Cohesive End Ligation 
The copy of the gene from the seven species was inserted into respective expression 
plasmids using a cohesive end ligation protocol. One important step in the procedure was 
to maintain a 3:1 molar ratio between insert and vector for efficient ligation. After 
quantifying the digested genes and expression vector, the fmoles of each was calculated 
using the formula: 
lug DNAbp 
ug DNA = fmoles DNA x — x (Eqn. 2) 
7,000 finole lOOObp 
The values calculated governed the amount of insert and vector incorporated into the 
ligation mix. The overall ligation reaction system is described in Table 3.6. 
Table'. 3.6. Typical ligation reaction set-up. 
Reagent 
Insert: vector 
T4 DNA ligase 
(New England Biolabs) 
T4 DNA ligase buffer 
(New England Biolabs) 
dH20 
Quantity 
3:1 molar ratio 
20 Units 
IX dilution 
Up to 15 uL 
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The ligation reaction was incubated at room temperature overnight. In addition, a control 
ligation reaction with no insert included was performed for determination of vector 
double digest efficiency. 
3.1.10. Preparation of Electrocompetent Escherichia co/iDH5a Cells 
A fresh culture of E. coli DH5a cells was grown overnight in 2.5 mL LB at 37°C with 
agitation. The following morning, 250 mL LB was inoculated with 1.0 mL of the fresh 
culture and the cells were incubated at 37°C with agitation approximately four hours until 
OD600 between 0.4 and 0.6 was reached. The cell suspension was centrifuged at 4,000xg 
for 15 minutes at 4°C in sterile tubes. The cells were resuspended in 250 mL cold 10% 
glycerol and centrifuged at 4,000xg for 10 minutes at 4°C. The cellular pellet was 
resuspended in 50 mL cold 10% glycerol and centrifuged for 10 minutes at 4,000xg at 
4°C, repeating an additional two times. Upon completion of the third wash, the E. coli 
DH5a cells were suspended in 500 uL cold 10% glycerol; then aliquoted into 50 uL 
volumes into microcentrifuge tubes and frozen at -80°C. 
3.1.11. Electroporation Transformation of Escherichia coli DH5a Cells. 
A 50 uL aliquot of the E. coli DH5a cells was thawed on ice; 2 uL of the ligation mix 
was added. The ligation-DH5a mix was transferred into 2.0mm electroporation cuvettes 
(BioRad, USA) and kept on ice. The electroporation cuvette was loaded into BioRad's 
Gene Pulser® X cell electroporation machine where an electrical pulse: 4.5 milliseconds, 
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3500 mV was sent through the cells. After the pulse, the transformed DH5a cells were 
suspended in 1 mL SOC broth (App. 2) and incubated at 37°C for 45 minutes with 
agitation. The culture was then plated on LB agar with kanamycin antibiotic selection, 
incubated overnight at 37°C. 
3.1.12. Screening of Transformed Escherichia coli DH5a Colonies 
Individual E. coli DH5a colonies were plucked from the overnight growth plates and 
incubated in 2.0 mL LB with 2uL of 2mg/mL kanamycin (LB & Kan) added, overnight 
at 37°C with agitation. After the overnight incubation period, 1.0 mL of the culture was 
aliquoted into a microcentrifuge tube and centrifuged at 13,000 rpm for 1 minute 
preparing the cells for plasmid isolation via a boiling mini-prep protocol. The cellular 
pellet was resuspended in 500 uL STET buffer (App. 2). A 10 uL aliquot of a lOmg/mL 
lysozyme (Invitrogen) was added then the STET-cell suspension was heated in a boiling 
water bath for 4 minutes. After boiling the samples were centrifuged at 13,000 rpm for 
10 minutes at 4°C; the pellet was removed with a sterile toothpick. Isopropanol, 500 uL, 
was added to the supernatant, mixed by inverting then incubated at -20°C for 20 minutes. 
The supernatant-isopropanol solution was centrifuged at 13,000 rpm for 10 minutes at 
4°C to pellet plasmid DNA. The pellet was washed with 200 uL 70% ethanol, air dried 
for 10 minutes then resuspended in 30 uL dH20. 
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3.1.13. Screening Isolated Plasmids for cDNA Insert by Restriction Endonuclease 
Digest 
The isolated plasmids from the boiling mini-prep were screened for positive inserts of 
the cDNA from the seven species (Table 3.1) by digesting 3 uL of the plasmid with 
appropriate enzymes for 1 hour at 37°C (Table 3.7). 
3.7. Standard plasmic 
Reagent 
Plasmid 
RE1 
RE2 
NEBuffer 4 
Bovine Serum Albumin 
(New England Biolabs) 
dH20 
digestion reaction 
Rat, Mouse, 
Xenopus 
3uL 
Ndel- 10 U 
Sad- 10 U 
IX dilution 
0.1 ug/uL 
Up to 20 uL 
Drosophila, C. elegans, 
Arabidopsis, Yeast 
3uL 
Ndel-10 U 
BamHI- 10 U 
IX dilution 
N/A 
Up to 20 uL 
Ten microlitres of each digest was aliquoted into microcentrifuge tubes containing DNA 
loading dye to yield a final concentration of 2%. The samples were loaded onto a 100 
mL 1% agarose gel (Invitrogen) with EtBr and electrophoresed at a constant current 35 
mA until the dye front was two-thirds down the gel. The gel was then visualized using a 
Chemilmager™ System (Alpha Innotech Corp) by UV irridation. 
Positive results were colonies which contained a DNA insert the appropriate size for 
one of the seven species (Table 3.1) and the reaction cross referenced back to a stock 
bacterial culture. Cultures proving to be positive for insert-expression vector plasmids 
were used to inoculate 250 mL LB & Kan solution for overnight growth in preparation 
for a large scale plasmid midi-prep using Qiagen® Plasmid Midi Kit as described in 
section 3.1.3. Aliquots of the isolated plasmids were sent to Macrogen Inc. (Korea) for 
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sequencing. The genes were sequenced with T7 forward and T7 reverse primers. Up to 
three individual colonies were sequenced to ensure a minimum of one was the correct 
sequence. Macrogen Inc. sequence results (App. 3) were compared against the 
appropriate genes, no point mutations found. 
3.2. Purification of Recombinant Proteins 
3.2.1. Protein Expression in E. coli BL 21: Transformation and Induction Time 
Course 
Heat-shock competent E. coli BL21 (Novagen®) were transformed with the gene 
containing expression vector using the heat shock protocol described in section 2.1.2. 
The transformed BL21 cells were streaked on LB plates with kanamycin selection, 
incubated overnight at 37°C. A fresh over night colony inoculated a 3 mL LB & Kan 
solution and was incubated overnight at 37°C with agitation. 
Two separate 20 mL LB & Kan Erlenmeyer flasks were inoculated with 1.0 mL of the 
overnight culture. Both cultures were grown at 37°C with agitation until log growth 
defined as an OD600 between 0.6 - 0.8. Upon achieving log growth, a 1.0 mL sample 
from each culture, designated as time zero, was removed and the OD6oo was measured 
using an Ultrospec® 1000 (Biochrom) spectrophotometer. This OD6oo served as a 
constant for correlating further induced and uninduced samples over the time course 
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to ensure a consistent number of cells in downstream experiments. This correlation 
ensures that protein levels are due to expression and not concentration differences. 
At t = 0, recombinant protein expression was induced in one culture by inoculation 
with 1 M stock isopropyl-P-D-thiogalactoside (IPTG) (Sigma, Missouri USA) to a final 
concentration of 1.5 mM. The second culture remained uninduced. Further 1.0 mL 
aliquots were removed from both cultures at 0.5 hour, 1 hour, 1.5 hour, 2 hour, then upon 
the hour until 8 hours. Remaining cultures were incubated under agitation overnight. 
Each timed sample collected was centrifuged in a microcentrifuge tube at 13,000 rpm for 
2 minutes to pellet the cells correlated to ODeoo at t = 0. The pellets resuspended in 50 
uL of 2X sodium dodecyl sulphate (SDS) with 10% P-mercaptoethanol loading dye 
(App. 2) then boiled for 3 minutes. 
Ten microlitre aliquots were loaded onto a sodium dodecyl sulphate 12% 
polyacrylamide, 37:1 arcylamide/N,N'-methylenebisacrylamide (Invitrogen) (SDS 
PAGE) gel. The SDS PAGE was electrophoresed at constant 150 V using a IX Tris-
Glycine running buffer (App. 2) until the bromophenol dye front ran off of the gel. 
3.2.2. Staining of SDS PAGE 
After electrophoresing, the SDS PAGE was stained to visually enhance protein 
banding. Two staining techniques were used. 
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3.2.2.1 Coomassie Staining Protein 
The SDS PAGE was carefully removed and fixed in a Coomassie Blue stain (App. 2) 
overnight with gentle agitation. The gel was destained using several changes of a 
destaining solution (App 2) until the gel background was clear of stain but the protein 
bands were still visible. The gel was rehydrated in deionized water then analyzed for 
protein expression with images taken under white light using Chemilmager™ System 
(Alpha Innotech Corp). 
3.2.2.2 Silver Staining Protein 
SDS PAGE was silver stained using Silver Stain Plus kit (BioRAD). Silver staining was 
provides a greater resolution of protein banding and was used to check the purity of the 
recombinant protein. The gel was fixed for 20 minutes with gentle agitation in 200 mL of 
Fixative Enhancer solution (App. 2). The gel was rinsed with 200 mL MilliQ H2O for 10 
minutes with gentle agitation. The rinse was repeated once. The gel was stained and 
developed in a staining solution (App. 2) prepared five minutes before use, for three 
minutes; the staining solution was removed and the staining was stopped with the 
addition of 100 mL of a 5% acetic acid solution. The gel was rehydrated in dHaO then 
visualized on a Chemilmager™ (Alpha Innotech Corp) under white light. 
3.2.3. Protein Expression in E. coli BL 21 
After determining the optimal time for protein expression from the time courses, 250 
mL LB & Kan solution was inoculated with overnight fresh culture of transformed E. coli 
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BL21. Upon reaching OD600 between 0.6 - 0.8, a 1 mL aliquot of culture was saved as 
the uninduced control while the balance of the culture was induced to express 
recombinant protein with the addition of a 1 M stock IPTG solution to a final 
concentration of 1.5 mM IPTG. The culture was then incubated at 37°C with agitation 
for the predetermined optimal time. The cells were pelleted at 3500 rpm in a Beckman 
centrifuge with a JA25.50 rotor then stored at -80°C. 
3.2.4. Protein Concentration Determination by Bradford Assay 
Recombinant proteins were quantified using a Bradford assay. A standard curve using 
Bovine Serum Albumin (BSA) (New England Biolabs), concentrations ranging from 1 
ug/uL to5 fig/uL, was generated at OD595. Recombinant proteins concentrations were 
determined by measuring their OD595 after the addition of Protein Assay Dye Reagent 
(BioRad, Canada) then multiplying by the constant from BSA standard curve. 
3.2.5. Determination of Solubility of Expressed Recombinant Protein 
After successful protein induction in E. coli BL21, the expressed recombinant protein 
solubility was determined. In order to determine if the recombinant protein was in the 
soluble or insoluble fraction of the BL21 cell lysate, an analysis of both the soluble and 
insoluble fraction for the recombinant protein was undertaken. The harvested induced 
cells were resuspended in a lysis buffer (App. 2) where a final concentration of 1 mg/mL 
lysozyme was added and the solution was incubated on ice for 30 minutes. Following 
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lysis, cells were subjected to sonification, 6x10 second cycles with a 3 second pause 
using a Sonic Dismembrator Model 100 (Fisher Scientific) on ice. The lysate was 
centrifuged at 10,000xg at 4°C for 30 minutes. The supernatant containing soluble 
proteins was saved; the remaining pellet, containing membrane and insoluble protein 
fraction was resuspended in a denaturing lysis buffer (App. 2). The lysate was kept in 
suspension to provide time for protein denaturation by orbital rotation for two hours. The 
cellular debris was pelleted via centrifugation, 10,000xg at 4°C for 30 minutes. The 
supernatant containing insoluble proteins was kept for analysis by SDS-PAGE. 
Ten microlitre aliquots of the soluble and insoluble fractions were prepared for 
analysis by adding 10 uL of 2XSDS loading dye (App. 2), boiling for 3 minutes 
prior to loading in a 12% SDS PAGE, electrophoresing at constant voltage, 150 V until 
the bromophenol blue dye front exited the plate at the bottom. The gel was stained with 
Coomassie Blue (App. 2) overnight. Following destaining, described in section 3.2.2.1, 
the gel was visualized under white light using Chemilmager™ and protein solubility was 
determined by comparing uninduced, induced samples with the soluble and insoluble 
lysates. 
3.2.6. Protein Purification from E. coli BL21 Cellular Lysate 
The recombinant protein containing lysate was passed through nickel-nitrilotriacetic acid 
resin (Ni-NTA) Spin columns (QIAGEN). Ni-NTA spin columns were used as 
the recombinant proteins had a six consecutive histidine residue tag (6X His-Tag) 
incorporated at their amino terminus during translation. The Ni-NTA resin has a high 
selectivity for 6X His Tag recombinant proteins. (Ni-NTA Spin Handbook, 2003). 
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3.2.7. Purification under Denaturing Conditions 
After solubility of the recombinant protein was established, protein purification was 
performed under denaturing conditions. Protein samples were loaded in 8M urea (App. 
2) with elution under decreasing pH wash conditions. Initially the pelleted BL21 cells 
from a 50 mL induced culture described in section 3.2.1, were exposed to 8M Urea, 
pH 8.0 for two hours with gentle agitation in order to provide time for the urea to 
solublilize the inclusion bodies, denature the recombinant protein, and expose the 6X 
His-Tag. The lysate was centrifuged at 10,000xg for 30 minutes at 20°C. Six hundred 
microlitres of the supernatant was loaded onto an equilibrated (8M urea, pH 8.0) Ni-NTA 
spin column and subjected to a 700 rpm spin for 2 minutes. The cleared lysate was saved 
for analysis. The Ni-NTA resin bed was washed with consecutively decreasing pH wash 
of 8M urea and the proteins were eluted at pH 6.2, 6.1 and 6.0 (Table 3.8). Aliquots from 
the washes and elutions were electrophoreses on a SDS PAGE described in section 3.2.1, 
and were analyzed under white light using Chemilmager™. 
Table 3.8. 8M urea wash and elution pH steps 
Fraction 
Washl 
Wash 2 
Wash 3 
Wash 4 
Elution 1 
Elution 2 
Elution 3 
PH 
6.7 
6.6 
6.5 
6.4 
6.2 
6.1 
6.0 
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Elution of the recombinant protein initially targeted at pH 6.0 as previously suggested by 
an earlier Lee lab member however the elution actually occurred at pH 4.5 (Table 3.9). 
Table 3.9. 8 M urea buffer with 10 mM imizadole 
wash/elution fractions. 
Fraction 
Washl 
Wash 2 
Wash 3 
Wash 4 
Elution 
pH 
6.7 
6.3 
5.9 
5.0 
4.5 
3.2.7.1. Gradient pH Chromatography Column Purification 
A gradient pH chromatography purification procedure was undertaken with Drosophila 
and Arabidopsis using a 20 mL Ni-NTA matrix (Sigma) packed into a 2.5cm x 70cm 
chromatography column and equilibrated with 8M urea, pH 8.0. After loading with the 
insoluble lysate, a gradient was set-up between the 8M urea, pH 6.7 and 8 M urea, pH 4.5 
using an ISCO Model 160 Gradient Former; the flow rate was set at 1.2 mL/minute. One 
milliliter fractions were collected using a Foxy® Jr. Fraction Collector (ISCO). At the 
end of each run, the column was washed with 70% ethanol and re-equilibrated with the 
8M urea buffer, pH 8.0. 
3.2.7.2. Inclusion Body Protocol for Recombinant Protein Purification 
When recombinant protein induction was not optimum in the BL21 cells, an inclusion 
body protocol was utilized in an attempt to lessen the amount of competing bacterial 
proteins for the Ni-NTA resin bed. A fresh, induced, 200 mL culture was pelleted as 
described in section 3.2.1; the pellet was resuspended in 8 mL of a 20 mM Tris-Cl, pH 
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8.0, sonicated 4x10 seconds using Sonic Dismembrator Model 100 (Fisher Scientific) 
on ice. The lysate was centrifuged at 10,000xg at 4°C for 10 minutes. The supernatant 
was saved for analysis. The pellet was resuspended in 6 mL of cold 2M urea containing 
20 mM Tris-Cl, 0.5 M NaCl, 2% Triton X-100 pH 8.0. The suspension was incubated 
overnight with gentle agitation. The solution was sonicated and centrifuged as described 
(3.2.5). The supernatant was saved for analysis. The remaining pellet was resuspended 
in 10 mL of 6M Urea containing 20 mM Tris-Cl, 0.5 M NaCl, 5 mM imidazole, pH 8.0 
and kept in suspension with agitation for 30 minutes followed by centrifugation for 15 
minutes. The supernatant was saved for analysis. 
Six hundred microlitres of the 2M urea fraction with the full length rat recombinant 
protein was passed through an equilibrated (2M urea, pH 8.0) Ni-NTA spin column 
(QIAGEN) then washed sequentially with 2M urea (App. 2), decreasing pH: 8.0, 6.3, 5.9 
with protein elution at pH 4.5. 
3.2.8. Protein Purification oiRattus norvegicus After Removal of the Trans 
Membrane Domain 
The removal of a considerable portion of the trans-membrane domain from rat was 
achieved by digesting with restriction endonuclease Bam HI (Invitrogen) which removed 
a 19 amino acid residue on the carboxy terminus, (Figure 3.1). R. norvegicus cDNA, 
without the trans-membrane domain (Rat-ATMD) was ligated into pET28a, section 3.1.9. 
and induced (3.2.1). 
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MAVDITLLFRASVKTVKTRNKALGVAVGGGADGSRDELFRRSPR 
PKGDFSSRAREVISHIGKLRDFLLEHRKEYINAYSHTMSEYGRMTDTERDQIDQDAQI 
FMRTCKDAIQQLRTEAHKEIHSQQVKEHRTAVLDFVEDYLKRVCKLYSEQRAIRVKRV 
VDKKRLSKLEPEPHTKRKEPASEKSSHNASQDSEEKPAAEDLPEKPLAESQPELGTWG 
DGKGEDELSPEEIQMFEQENQRLIGEMNSLFDEVRQIEGKVVEISRLQEIFTEKVLQQ 
ETEIDSIHQLVVGATENIKEGNEDIREAIKNNAGFRVWI LFFLVMCSFSLLFLDWYDS 
| Bam HI restriction site 
Figure 3.1 Rat syntaxin 18 amino acid sequence (Altschul L. 1997) with the trans-
membrane domain indicated in bold. The arrow indicates the section cleaved to 
generate rat recombinant protein minus a portion of the trans-membrane domain. 
Rat-ATMD recombinant protein was purified from cell lysate using Ni-NTA spin 
columns (QIAGEN). A freshly induced, 200 mL LB & Kan solution was divided into 10 
mL aliquots, centrifuged at 3000 rpm for 5 minutes at 4°C; the cells were stored at -80°C. 
Upon thawing on ice, the cells were resuspended in 8M Urea, pH 8.0 (App. 2) and 
incubated with agitation for 1 hour at room temperature. 
The lysate was centrifuged at 10,000xg for 30 minutes at room temperature; 600 uL of 
the supernatant was loaded onto an equilibrated (8M urea, pH 8.0) Ni-NTA spin column 
(QIAGEN) and centrifuged at 700 rpm for 2 minutes. The cleared lysate was saved for 
analysis. Urea buffers, (App. 2) had their pH adjusted immediately prior to use. The 
resin of the Ni-NTA spin column (QIAGEN) was washed twice with 400 uL of 8M urea, 
pH 6.3, each wash was followed by a spin at 700 rpm for 2 minutes. The Ni-NTA resin 
bed was washed twice with 200 uL of 8M urea, pH 5.9 (App. 2); each wash was followed 
by a spin at 700 rpm for 1 minute. All wash fractions were collected and saved for 
analysis. The Rat-ATMD recombinant protein was eluted in two - 150 uL volumes of 
8M urea, pH 4.5. 
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3.2.9. Western Blot Analysis of Recombinant Proteins 
Western blot analyses were performed on recombinant rat, mouse, Drosophila and 
Arabidopsis proteins as a means to identify that a recombinant protein had indeed been 
expressed and purified, as well as a method to confirm the identity of the purified full 
length and without the trans-membrane domain, R. norvegicus recombinant protein. 
Three separate primary antibodies were used for the Western blot analysis. First primary 
antibody, a rabbit generated polyclonal anti-syntaxin against a 15 amino acid 
oligopeptide from human syntaxin 18 as an antigen (animal # 9959, week 10, Invitrogen). 
Secondly, rabbit generated polyclonal 6X-His epitote tag (Affinity BioReagents, USA) 
and thirdly, a rabbit polyclonal to RNase A (GeneTex®, USA). The HRP-conjugate 
secondary antibody used was anti-rabbit. 
3.2.9.1. Western Blot Protocol 
Recombinant protein samples were loaded onto a 15% SDS-PAGE and electrophoresed 
at a constant 150 V as described previously in section 3.1.14. The gel was transferred 
onto nitrocellulose membrane for 1 hour at a constant 100V (App. 2). The membrane 
was blocked in 5% milk buffer (App. 2) overnight at 4°C with gentle agitation. The 
membrane was washed in 0.5% milk buffer for 15 minutes at room temperature then 
incubated with the primary antibody (1:2500 dilution for anti-syntaxin 18 & anti-RNase 
A; 1:1000 dilution for anti-6X-His antibody tag) in 0.5% milk buffer for one hour at 
room temperature with gentle agitation. 
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The blot was rinsed 3X with 0.5% milk buffer, agitating for 5 minutes. The 
membrane was incubated with an anti-rabbit-HRP conjugate, diluted to 1:3500 in 0.5% 
milk buffer for 30 minutes at room temperature with gentle agitation. The membrane 
was rinsed in 0.5% milk buffer for thirty minutes with three changes of 0.5% milk buffer 
during this time. The signal was developed using SuperSignal® West Pico 
Chemiluminescent substrate (PIERCE, USA) as per the manufacturer's protocol, and the 
blot then visualized with a Chemilmager™ (Alpha Innotech Corp). The blot was 
visualized using 2 frames, where frame 1 ran for 1 minute and frame 2 ran for 3 minutes. 
3.2.9.2. Western Blot Stripping Protocol 
When required, the Western blots were stripped to allow for probing with different 1° 
antibody. The membrane was incubated at room temperature with agitation in a preheated 
to 50°C stripping buffer (App. 2) for 30 minutes. The stripping buffer was exchanged 
once during the 30 minute time period. The membrane was rinsed in the 0.5% milk 
buffer for 10 minutes with one change of buffer before being subjected to the protocol as 
previously described. 
3.3. Dialysis and Endonucleolytic Testing 
3.3.1. Dialysis of Rat-ATMD in Preparation for Assessment of Endonucleolytic 
Activity 
As recombinant Rat-ATMD protein was purified under denaturing conditions it was 
necessary to re-nature the recombinant protein. Refolding was accomplished by dialysis 
to remove urea and change pH to 7.4. Three separate dialysis buffers were used and each 
separate refolding protocol was tested for endonucleolytic activity. The preparatory step 
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for dialysis was the same procedure for each of the three methods. 150 |^ L of purified 
Rat-ATMD recombinant protein was concentrated in a 10,000 dalton Nanosep® device, 
by centrifugation at 14,000xg for 3 minutes at 4°C. Fifty microlitres of the concentrated 
Rat-ATMD recombinant protein was loaded into separate Slide-A-Lyzer mini dialysis 
units (Pierce). Each subjected to one of the three different dialysis protocols described. 
3.3.1.1. Dialysis Buffer Exchange with Decreasing Concentrations of Urea and 
Step Increases of pH 
This dialysis buffer exchange occurred over two days with two buffer exchanges every 
third hour, the third exchange was kept overnight at 4°C, followed by two further buffer 
exchanges every third hour (Table 3.10). Each buffer volume was 250 mL and was kept 
stirred with a magnetic stir bar. 
Table 3.10. Dialysis buffers for gradual decrease in urea 
concentration and gradual increase in pH. 
Exchange period 
Initial 
3 hour 
Overnight 
3 hour 
3 hour 
Buffer composition 
6Murea/pH5.0 
4Murea/pH5.8 
2 M urea/ pH 6.3 
1 M urea/pH 6.7 
0 M urea/DEPC/pH 7.4 
3.3.1.2. Dialysis Buffer Exchange with Decreasing Urea Concentration, pH 
Maintained at 7.4. 
The second dialysis used the same buffer and time exchange set-ups as in section 3.3.1.1 
however the pH of each buffer was 7.4 (Table 3.11). 
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Table 3.11. Dialysis buffer exchange; gradual decrease 
in urea concentration, pH 7.4 
Exchange period 
Initial 
3 hour 
Overnight 
3 hour 
3 hour 
Buffer composition 
6 M urea/pH 7.4 
4 M urea/pH 7.4 
2 M urea/ pH 7.4 
1 M urea/pH 7.4 
0 M urea/DEPC/pH 7.4 
3.3.1.3. Dialysis Buffer Exchange with Guanidine/p-mercaptoethanol 
A third dialysis was performed where guanidine/(3-mercaptoethanol was included as a 
denaturant to disrupt sulphide bonds. The dialysis procedure involved taking 50 uL of 
the purified recombinant Rat-ATMD protein and adding five 2 uL aliquots of a solution 
containing 8 uL of 6M guanidine HC1 with 2 uL of P-mercaptoethanol with mixing after 
each addition. The buffer composition (Table 3.12) remained constant throughout the 
five hour dialysis, with 3 - 500 mL buffer exchanges. 
Table 3.12. Guanidine HC1/ p-mercaptoethanol 
dialysis buffer. 
20 mM Tris pH 7.4 
lOmMMgOAc 
lOmMDDT 
(DL-dithiothreitol) 
1 mM L-Glutathione Reduced 
0.1 mM Glutathione oxidized 
3.3.2. Linearization of pUC19 Plasmid Containing c-Myc Coding Region 
Determinant Sequence 1705 -1792 nts 
A DNA sequence from the c-Myc Coding Region Determinant (CRD), 1705 - 1792 
nucleotides (nts), CRD-pucl9 plasmid was provided for this research by Dr. Chow Lee. 
The c-Myc CRD-pUC19 plasmid was cut with restriction endonuclease EcoRI 
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(Invitrogen) in preparation for transcription to produce transcripts of defined size. The 
linearization digest (Table 3.13) was incubated for 1.5 hours at 37°C. Immediately 
following digestion 50 ug/mL of Proteinase K (EM Sciences), was added and the mixture 
was incubated for a further 30 minutes at 37°C. 
Table 3.13. Linearization of c-Myc CRD-pUC19 reaction 
c-MycCRD-pUC19 
Eco RI (Invitrogen) 
REACT 3 (Invitrogen) 
Sterile dH20 
3-60g 
1 unit 
IX dilution 
Up to 20 uL 
After the Proteinase K incubation, diethyl pyrocarbonate (DEPC) (Sigma) MilliQ H20 
was added to a final volume of 200 uL with the addition of lOuL 10% SDS, 0.5M EDTA, 
pH 8.0, and 4uL 5M NaCl. The digest was subjected to a standard phenol:chloroform 
extraction followed by an ethanol/3M sodium acetate precipitation where double the volume 
of 100% ethanol along with 1/10 the volume of 3M sodium acetate were added. The solution 
was gently inverted to mix and incubated at -20°C for 30 minutes followed by centrifugation 
at 13,000 rpm for 20 minutes at 4°C. The DNA pellet was washed with 70% ethanol then air 
dried at room temperature for 10 minutes. The DNA pellet was resuspended in 20 uL DEPC 
MilliQ H2O. A 2 uL aliquot was electrophoresed on a 1% agarose gel with EtBr to confirm 
linearization as described previously in section 3.1.13. The DNA was quantified using an 
ND-1000 UV Spectrophotometer (Nanodrop). 
3.3.3. Transcription of c-Myc CRD RNA 
Transcription of c-Myc CRD RNA was carried out by using SP6 RNA polymerase-mediated 
in vitro transcription kit (MEGAscript, Ambion, USA). The transcription reaction consisted 
of 12, 5 ug of linearized c-Myc CRD-pUC19, 5 mM each of ATP, CTP, GTP, UTP, 
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2.5 mM dithiothreitol (DTT) (Promega, USA), IX reaction buffer (Ambion), 40 Units 
RNasin (Promega) and 40 Units SP6 polymerase enzymes (Ambion). The reaction mix was 
brought up to 40 uL with nuclease-free H2O (Ambion). The transcription reaction was 
allowed to progress for 1.5 hours at 37°C; the reaction was stopped with the addition of 2 
Units of TURBO DNase (Ambion) for an incubation period of 15 minutes at 37°C. 
The reaction volume was brought up to 150 uL with nuclease-free H2O (Ambion) and the 
newly transcribed c-Myc CRD RNA was isolated by phenolxhloroform extraction followed 
by ethanol/5 M sodium acetate precipitation where 2.5 volumes of 100% ethanol was added 
to the c-Myc CRD RNA containing fraction with 1/10 volume of 5 M sodium acetate. The 
solution was gently inverted, incubated at -20°C for 45 minutes. The c-Myc CRD RNA was 
pelleted by centrifugation, 13,000 rpm, 20 minutes at 4°C. The RNA pellet was washed with 
70% ethanol, air dried for 10 minutes at room temperature then resuspended in 30 fiL DEPC 
H2O. A 2 uL aliquot was electrophoresed on a 2.5% agarose gel with EtBr (3.1.13) and 
visualized under irridation to view the quality of the c-Myc CRD RNA using a 
Chemilmager™ System (Alpha Innotech). The c-Myc CRD RNA was quantified on a ND-
1000 UV spectrophotometer (Nanodrop) and stored at -80°C. 
3.3.4. Dephosphorylation of c-Myc CRD RNA 
The c-Myc CRD RNA was dephosphorylated at the 5' terminus in preparation for radio-
labeling with y32P-ATP (Amersham BioSciences). The dephosphorylation reaction contained 
6.5 jig c-Myc CRD RNA, 10 Units of alkaline phosphatase from calf intestine (Roche 
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Diagnostics), IX dephosphorylation buffer, 5 mM DDT and 1 Unit of RNasin (Promega); 
with DEPC H2O added to a final volume of 100 uL. The reaction was incubated at 37°C for 
30 minutes followed by the addition of 100 uL DEPC H20, 1 uL of 0.5 M 
ethylenediaminetetra acetic acid (EDTA), 4 uL of 5M NaCl and 10 uL of 20% SDS. The 
dephosphorylated c-Myc CRD RNA was extracted using standard phenolxhloroform 
extraction followed by ethanol/3M sodium acetate precipitation where 2.5 volumes of 100% 
ethanol plus 1/10 volume of 3M sodium acetate were added. The solution was mixed by 
gently inverting then kept at -20°C for 30 minutes. The c-Myc CRD RNA was pelleted by 
centrifuging at 13,000 rpm at 4°C for 20 minutes. The RNA pellet was washed with 70% 
ethanol, air dried for 10 minutes at room temperature then resuspended in DEPC H2O. 
3.3.5. S'-y^P-RatUohibeHng of c-Myc CRD RNA 
The dephosphorylated c-Myc CRD RNA was 5 '-y32P radio labeled by phosphorylating 
with y32P-ATP (Amersham BioSciences). The reaction consisted of combining 
approximately 2 |ag of the dephosphorylated c-Myc CRD RNA with 5 mM DTT, 0.5 Units 
RNasin (Promega), IX Polynucleotide Kinase (PNK) Buffer (New England Biolabs), 30uCu 
y32P-ATP and 30 Units of T4 Polynucleotide Kinase (PNK) (New England Biolabs) with the 
addition of DEPC H2O to a final volume of 20 uL. The reaction was incubated at 37°C for 
one hour. After incubation, 30 uL DEPC H2O was added followed immediately by a spin at 
735xg for 2 minutes in a prepared ProbeQuant G-50 Micro Column (Amersham 
BioSciences). 
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A ten microlitre aliquot of urea/phenol loading dye (App. 2) was added to the filtered c-
Myc CRD y32P-ATP RNA then loaded onto a 6% polyacrylamide/7M urea (Fisher Scientific) 
denaturing gel and electrophoresed at a constant current, 25 mA in a 1XTBE running buffer 
for 60 minutes. 
A blanked Cyclone Storage Phophor Screen (Packard) was exposed for 1 minute to the c-
Myc CRD y32P-RNA denaturing gel. The exposed screen was visualized with a Cyclone 
Phospholmager (Packard) and OptiQuant software. A full-size image of the c-Myc CRD 
y32P-RNA gel was printed and used as a template by placing the image underneath the gel 
to identify the location of the c-Myc CRD y32P-RNA band. This gel area excised with a 
sterile scalpel and placed into a 1.5 mL sterile microcentrifuge tube. A 600 uL volume of 
elution buffer (App. 2) was added to the gel slice and incubated at 45°C for 5 hours with a 
vortex every hour. The elution mixture was centrifuged at 13,000 rpm for 5 minutes, the 
supernatant was transferred to a clean microcentrifuge tube and a standard phenol:chloroform 
extraction was performed. The c-Myc CRD y P-RNA was precipitated by an ethanol/3M 
sodium acetate precipitation where 2.5 volumes of 100% ethanol was added along with 1/10 
volume of 3M sodium acetate. The mixture was left at -20°C for 20 minutes then centrifuged 
at 13,000 rpm for 25 minutes at 4°C. The c-Myc CRD y32P-RNA pellet was washed with 
70% ethanol, air dried for 10 minutes then resuspended in 150 uL DEPC H2O. No 
quantification of radio activity was performed as the Packard 1600 TR liquid scintillation 
analyzer was down for repair. The c-Myc CRD y32P-RNA was stored at -20°C. 
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3.3.6. Testing the Purified Rat-ATMD Recombinant Protein for Endonucleolytic 
Activity. 
The purified Rat-ATMD recombinant protein was tested for endonucleolytic activity by 
performing an in vitro endonuclease assay. The components of the reaction mixture used for 
the endonuclease assay are listed in Table 3.14. 
Table 3.14. Reaction mixture used for endonuclease assay 
Reagent 
Tris pH 7.4 
DTT 
MgOAc 
Spermidine (Sigma) 
DEPC H20 
Concentration 
10 mM 
2mM 
2mM 
0.1 mM 
As required for dilution 
Eighteen microlitres of endonuclease assay reaction mixture was aliquoted into 1.5 mL 
microcentrifuge tubes. The positive control for endonuclease activity was 0.4 Units of a 
35kDa nuclease (Barnes 2007). A blank control consisting of 4 uL DEPC H2O was included 
to ensure no contamination with outside nucleases during the procedure. All other proteins 
that were being tested for endonuclease activity were aliquoted at a minimum of 
1 \ig of protein. One microlitre of c-Myc CRD y32P-RNA was added to the side of the 
microcentrifuge tubes then all the tubes were simultaneously pulsed to ensure the 
•IT 
c-Myc CRD y P-RNA substrate entered the reaction mix at the same time. The reaction 
was incubated at 37°C for a maximum time of 10 minutes. The reaction was stopped with 
the addition of 10 uL urea/phenol dye (App. 2). 
The reactions were analyzed for endonucleolytic activity by electrophoresing 10 uL of 
each reaction on a 6% polyacrylamide /7M urea denaturing gel. The denaturing gel was 
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electrophoresed at a constant current of 23 mA for approximately 60 minutes in a IX TBE 
running buffer. The gel was transferred to filter paper, covered with Saran® wrap and dried 
on a gel dryer (LABCONCO) for 10 minutes. The dried gel was exposed to a Phosphor 
Image screen overnight. The image was visualized using the Cyclone Phospholmager and 
OptiQuant software. 
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4.1. Ligation and Recombinant Protein Induction, Expression, 
Purification and Endonucleolytic Assay. 
4.1.1. Ligation of R. norvegicus, M. musculus, X. laevis, D. melanogaster, C. elegans, 
S. cerevisiae and A. thaliana into Expression Vector pHTT7K 
The cloned homologous syntaxin cDNA for R. norvegicus, M. musculus, Xenopus, 
Drosophila, C. elegans, S. cerevisiae and Arapsidopsis was successfully ligated into 
expression vector pHTT7K (Figure 4.1) according to anticipated size (Table 2.1). 
Human syntaxin 18 cDNA is included in the figure for comparative purposes. 
DNA kb 
3 4 5 (6) 7 8 9 10 11 
Figure 4.1. Confirmation of ligation of homologous syntaxin cDNA from the seven 
species into expression vector pHTT7K. 1% Agarose gel. Lanel: L-pHTT7K 
(Ndel/SacI), 5100 bp, lane 2: Human syntaxin 18, 1000 bp, lane 3: R. norvegicus, 1500 
bp, lane 4: M. Musculus, 927 bp, lane 5: Xenopus, 921 bp, lane 6: 1 Kb Plus DNA ladder 
(Invitrogen), lane 7: L-pHTT7K (Ndel/Bam HI), 5100 bp, lane 8: Drosophila, 1361 bp, 
lane 9: C. elegans, 702 bp, lane 10: S. cerevisiae, 1302 bp, lane 11: Arabidopsis, 941bp. 
4.1.2. Sequencing Results for R. norvegicus, M. musculus, X. laevis, D. melanogaster, 
C. elegans, S. cerevisiae and A. thaliana. 
The pHTT7K plasmids containing the respective clones were sent to Macrogen Inc. 
(Korea) for sequencing (Appendix 3). The sequence of each syntaxin 18 clone was 
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checked for mutations by comparison to their respective cDNA sequences using BLASTn 
alignment tool (Astchul et al 1999). The cloned genes for the syntaxin homologs were 
found to have no nucleotide mutations within their nucleotide sequences. 
To verify that each cloned gene coded for a viable protein, each Macrogen sequence 
was translated using Amino Acid Translator Tool (Gasteiger et al 2003). Based on this 
analysis, C. elegans cDNA supplied by the National Institute of Genetics coded for a 
nonsense protein in all reading frames. C. elegans-pHTTJK construct was then used as a 
negative control for expression during all subsequent purification procedures. 
4.1.3. Recombinant Protein Induction in E. coli BL21 with Expression Vector 
pHTT7K Results for Rattus norvegicus, Mus musculus, Xenopus laevis, Drosophila 
melanogaster, Caenorhabditis elegans, Saccharomyces cerevisiae and Arabidopsis 
thaliana. 
BL 21 cells transformed with the respective expression vector, were induced with 
1.5mM IPTG and time courses were undertaken for Xenopus, Drosophila, C. elegans, S. 
cerevisiae and Arabidopsis following protocol outlined previously (section 3.1.14). No 
time course was undertaken for R. norvegicus and M. musculus clones as a previous Lee 
lab member indicated that their protein expression required overnight induction. As an 
indicator of protein expression, the emergence of enriched protein bands on SDS PAGE 
after Coomassie staining at the predicted protein sizes would be indicative of induction 
(Figure 4.2). Protein expression at the approximate size was observed for Xenopus, 
Drosophila and Arabidopsis while not for C. elegans and S. cerevisiae (Figure 4.2). 
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Figure 4.2 12% SDS-PAGE analysis of 
recombinant protein expression in 
pHTT7K, arrows indicate expected 
protein size. Expression observed at 7.5 
h for Xenopus, (A); 6.5h for Drosophila, 
(B) and Arabidopsis, (C). 
No expression observed for C. elegans 
(D), or S. cerevisiae (E). 
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4.1.4. Recombinant Protein Purification under Denaturing Conditions. 
In order to reduce competition between bacterial proteins and the recombinant 
proteins binding to the Ni-NTA resin, the cellular lysate was separated into soluble and 
insoluble fractions as a preliminary step for protein purification. Analysis of soluble and 
insoluble lysates on a Coomassie stained SDS PAGE indicated the overexpressed 
proteins were being sequestered in inclusion bodies (data not shown) therefore 
purification procedures using denaturing conditions were undertaken. 
The insoluble fractions of R. norvegicus, Xenopus, Drosophila, C. elegans, S. 
cerevisiae and Arabidopsis were passed through a Ni-NTA spin column (section 3.2.7), 
followed by washes using 8M urea buffer with decreasing pH following the previously 
described protocol, purifying human recombinant syntaxin 18 alongside for comparative 
purposes. The wash/elution fractions were analyzed on a Coomassie stained 12%SDS 
PAGE; small amounts of the recombinant proteins appeared to be eluting at pH 6.0 
(Figure 4.3), which appeared to agree with previous research results from others in the 
Lee lab. The R. norvegicus, Xenopus, Drosophila, C. elegans, S. cerevisiae, Arabidopsis 
recombinant proteins were concentrated using a Nanosep® concentrator (section 3.2.7) 
then electrophoresed on a 12% SDS PAGE and visualized by Coomassie stain (Figure 
4.3). What is apparent from these gels is that what was initially believed to be purified 
recombinant proteins from the individual species eluting at pH 6.0, was in fact a bacterial 
artifact of approximately 45 kDa in size, as collaborated by the C. elegans negative 
control as its purified extract also contains the artifact (Figure 4.3, lanes 6, 7). The 
purified Drosophila protein deteriorated during storage indicated by a blank lane (Figure 
4.3, lane 3). 
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Figure 4.3. 12% SDS PAGE analysis of purity of proteins from the seven species, elution 
in 8 M urea at pH 6.0. Lane 1: human 0.2p,g, Lane 2: R. norvegicus 0.2|ag, Lane 3: 
Drosophila, Lane 4: Xenopus 0.2|j.g, Lane 5: LMW protein marker (SigmaMarker™), 
Lane 6: Arabidopsis 0.4 \ig, Lane 7 & 8: C. elegans 0.2(ig, Lane 9 & 10: S. cerevisiae 
0.2ug. 
4.1.5. Arabidopsis thaliana and Drosophila melanogaster Recombinant Protein 
Purification Results. 
As Arabidopsis and Drosophila had appeared to have had adequate induction (Figure 
4.2, B and C) and insoluble lysate fractions from these inductions was still available, 
further protein purification strategies were applied to these fractions. The Xenopus 
expression initially had adequate induction (Figure 4.2A) and will be discussed further in 
section 5.6. 
The Arabidopsis and Drosophila insoluble lysate were both passed through Ni-NTA 
spin columns (QIAGEN) followed by washes with 8M urea buffer, including 10 mM 
imizadole. Afterwards, the respective wash and elution fractions were electrophoresed 
on a 15% SDS PAGE and Coomassie stained, (Figures 4.4 and 4.5). 
73 
CHAPTER 4 - RESULTS 
KDn 
55 
i 4 B n 
fee mm 
•37KDa 
1 2 3 4 5 6 7 
Figure 4.4. Arabidopsis purification results with 10 mM imizadole added to the 8M urea 
buffer. Lane 1: LMW protein marker (SigmaMarker™), Lane 2: wash pH 5.9, Lanes 3, 
4 & 5: wash pH 5.0, Lanes 6 & 7: elution pH 4.5. 
kDa 
55 
45 
36 
29 
24 
14 
6,0 
•we-
mi** 
2 
— 
.$•«!*'lW«,«|tr 
• _ 
1 
... 
-47kDa 
1 2 3 4 5 6 7 
Figure 4.5 Drosophila purification results with 10 mM imizadole added the 8M urea 
buffer. Lane 1: LMW protein marker (SigmaMarker™), Lane 2: wash pH 5.9, Lanes 3 & 
4: wash pH 5.0, Lanes 5, 6 & 7: elution pH 4.5. 
Both elution fractions indicate a protein band at the anticipated recombinant protein 
size, 47 kDa fox Drosophila (Figure 4.5, lanes 5 & 6) and 37 kDa Arabidopsis (Figure 
4.4, lanes 6 & 7). While the proteins were present at the anticipated sizes, numerous 
background bacterial protein bands where also present, indicating the Drosophila and 
Arabidopsis recombinant proteins were not pure enough for analysis by endonucleolytic 
assay after this single purification step. 
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To improve purity, a gradient pH chromatography technique was employed (section 
3.2.7.1). For both Drosophila and Arabidopsis where their insoluble fractions were 
loaded onto the Ni-NTA chromatography column and ran through the column with 
fractions collected for analysis. The fractions containing the recombinant protein for 
each species, as determined after visualizing on a SDS PAGE, were concentrated using a 
Nanosep®. A 10 uL aliquot was electrophoresed on a 15% SDS PAGE, Coomassie 
stained (Figure 4.6). 
KDo, Arabidopsis Drosophilia 
•47kDa 
•37kDa 
Figure 4.6. Arabidopsis and Drosophila protein containing fractions from gradient pH 
after Nanosep®. Lanes 1 & 2: Arabidopsis pooled fractions 0.2 ug, Lane 3: LMW 
protein marker (SigmaMarker™), Lane 4: blank, Lane 5: Drosophila pooled fractions 0.2 
MS 
To confirm that Arabidopsis and Drosophila recombinant proteins were indeed in the 
fractions, a Western blot with an anti 6X -His antibody was performed (section 3.2.9.1) 
(Figure 4.7). His-tagged CRD-BP was used as a positive control for the experiment 
(Figure 4.7, lane 1). 
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The pooled fractions which were believed to have had the recombinant proteins for 
Drosophila and Arabidopsis were negative for the 6X-His tag (figure 4.7, lanes 3-5). 
4.1.6. S. cerevisiae Recombinant Protein Expression 
S. cerevisiae insoluble lysate was included in the Western blot to determine if the 
syntaxin 18 homolog recombinant UFE 1 protein, was being expressed but masked in the 
Coomassie stained SDS-PAGE by bacterial protein bands as no enriched protein 
expression band was visible over the time course experiment (Figure 4.2 E). No band 
corresponding to the predicted size for recombinant UFE 1 (42 kDa) after probing with 
the anti 6X-His antibody indicating that no tagged recombinant protein was expressed 
(Figure 4.7, lane 6). 
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Figure 4.7. Anti 6X-His Western blot on Arabidopsis, Drosophila, R. norvegicus-ATMD 
and S. cerevisiae insoluble lysate. Lane 1: positive control, CRD-BP 2.0 ug, Lane 2: 
Rainbow MW marker (Amersham), Lane 3 & 4: Arabidopsis purified recombinant 
protein 1.0 (j,g, Lane 5: Drosophila purified recombinant protein 1.0 \ig, Lane 6: Yeast 
insoluble lysate, Lanes 7 & 8: Rat-ATMD purified recombinant protein 1.0 ug. 
Rat-ATMD purified recombinant protein, which will be discussed in section 4.1.8, was 
included in the anti-6X-His Western blot to confirm expression of a recombinant protein. 
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4.1.7. Rattus norvegicus & Mus musculus Recombinant Protein Purification in the 
pHTT7K Plasmid. 
M. musculus recombinant protein expression in BL21 cells was successful following 
the overnight protocol as indicated by SDS-PAGE analysis (Figure 4.8). 
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Figure 4.8. 15% SDS PAGE analysis of M. musculus recombinant protein expression in 
pHTT7K. Lane 1: LMW protein marker (SigmaMarker™), Lane 2: Uninduced, Lane 3: 
Mouse induced, overnight. 
As the Arabidopsis-^WYTIK construct had consistently demonstrated recombinant 
protein induction, the Arabidopsis-pWTTlK construct had the gene was removed by 
digestion, followed by ligation of R. norvegicus syntaxin 18 cDNA into the vector 
backbone that had demonstrated protein over expression. 
To eliminate the possibility that bacterial proteases could be degrading the 
recombinant protein, an E. coli BLR strain, which is deficient in two proteases 
(Novagen®), was analyzed in tandem with the BL 21 cells for protein expression. For 
the R. norvegicus pHTT7K expression, overnight induction did not indicate protein 
expression in either E. coli strain (Figure 4.9A). BLR and BL 21 competent cells were 
transformed with the new rat- pHTT7K construct and induced following the standard 
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protocol. Induction at 40 kDa was observed in both strains as a thickened band (Figure 
4.9B). 
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Figure 4.9. 15% SDS PAGE analysis of R. norvegicus protein expression comparison 
between original pHTT7K (A) and new pHTT7K (B) in E. coli BL21 and BLR strains. 
A. Induction of rat protein in original pHTT7K, BL 21 (lanes 2 & 3) and BLR (lanes 4 & 
5). B. Rat protein induction in Arabidopsis-pHTTIK, BL 21 (lanes 2 & 3) and BLR 
(lanes 4 & 5). 
After induction and separation into soluble and insoluble fractions, a Western blot was 
performed on the denatured insoluble lysates, using an anti-syntaxin 18 antibody, to 
confirm the presence of R. norvegicus from the new clone and M. musculus recombinant 
proteins before proceeding to purification (Figure 4.10). The blot confirmed expression 
of M. musculus and R. norvegicus recombinant syntaxin protein (Figure 4.10, lanes 1,2 
and 3 respectfully). Although M. musculus and R. norvegicus recombinant proteins have 
the same number of amino acids, there is a 9% difference in amino acid identity (Tables 
2.1, 2.2) which could explain the difference in molecular weight (Figure 4.10, lanes 2 
and 3). 
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Figure 4.10. Anti-syntaxin Western blot on R. norvegicus and M. musculus, insoluble 
lysate. Lanes 1 & 2: Rat insoluble lysate, Lane 3: Mouse insoluble lysate, Lane 4: 
positive control, human Syntaxin 18, 1.5ug. 
4.1.8. Rattus norvegicus and Mus musculus Purification Results using Inclusion Body 
Protocol 
The percentage of the over expressed protein to total protein contentwas estimated to 
be 10 - 20%, based upon a comparison to a standard recombinant protein expression 
figure in the Ni-NTA Spin Handbook (2003). As a relatively small percentage of the total 
protein in the lysates were the R. norvegicus and M. musculus recombinant proteins, the 
purification procedure was modified to focus on an inclusion body protocol to decrease 
the bacterial background proteins to reduce competition for sites on the Ni-NTA resin 
bed potentially decreasing recombinant protein yields. 
The M. musculus cellular lysate was subjected to the inclusion body protocol (3.2.7.2). 
The three washes generated from the protocol, Tris, 2M urea and 6M urea, were analyzed 
on a 15% SDS PAGE (Figure 4.11 A) and simultaneously on a Western blot, probed with 
anti-syntaxin 18 antibody (Figure 4.1 IB). Although the recombinant protein does not 
appear to be enriched in the Coomassie stained 15% SDS PAGE, (Figure 4.11 A), the 
Western blot probed with syntaxin 18 antibody indicates mouse recombinant protein is 
present in both 2M urea and 6M urea wash fractions (Figure 4.1 IB). 
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EXP 1 EXP 2 
Figure 4.11. M. musculus inclusion body lysates. Two separate inductions are shown. A: 
Coomassie stained, 15% SDS PAGE of the inclusion body washes. Mouse recombinant 
protein appearing in the 2M urea wash, lanes 2, 3, 7 and 8. B: Western blot with anti-
syntaxin 18. Mouse is appearing in 2M urea. A small amount of mouse recombinant 
protein is visible in the 6M urea wash, lanes 4 and 8. 
Following denaturing, the 2M urea washes containing M. musculus and R. norvegicus 
recombinant protein respectively were passed through a Ni-NTA spin column (QIAGEN) 
with elution at pH 4.5. When the 2M urea wash was passed through a Ni-NTA spin 
column, no protein band at the predicted 37 kDa (M musculus) or 40 kDa (R. norvegicus) 
sizes appeared in the elutant, as analyzing on a Coomassie stained SDS PAGE (data not 
shown). 
Throughout the purification trials, the newly construct vector was repeatedly induced 
however visible induction on a Coomassie stained SDS PAGE became sporadic, and a 
final induction followed by purification of rat-pHTT7K using the inclusion body protocol 
was attempted. Following denaturation, the 2M urea wash which previously had been 
established to contain the recombinant proteins sequestered in inclusion bodies, was 
passed through a Ni-NTA spin column (QIAGEN). The fractions were analyzed on a 
Coomassie stained 15% SDS PAGE where the flow through fraction (Figure 4.12, lane 2) 
indicates a thickened band at the approximate predicted size for R. norvegicus 
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recombinant syntaxin 18, however no recombinant protein is eluting at the expected pH 
of 4.5 (Figure 4.12, lanes 7-9), indicating further problems with the pHTT7K vector. 
1 2 3 4 5 6 7 8 9 
Figure 4.12. 15% ASDS-PAGE analysis ofR. norvegicus in cloned pHTT7K vector 
protein purification using inclusion body protocol. After the inclusion body purification 
protocol, 2M urea wash is ran through a Ni-NTA spin column; Lane 2 is the flow through 
which appears to contain rat recombinant protein, lanes 3 - 6 are washes of decreasing 
pH, lanes7-9: is the elution fraction at pH 4.5 which is negative for rat recombinant 
protein. 
4.1.9. Ligation, expression and Purification of Full Length Rattus Norvegicus in 
Protein Expression Vector pETa28. 
A new over expression vector, pET28a was obtained from Novagen. The full length 
R. norvegicus syntaxin 18 gene was excised from pHTT7K by restriction endonuclease 
digestion and ligated into the pET28a expression vector, linearized with the same 
restriction enzymes. Successful ligation of cloned rat syntaxin 18 into pET28a is 
observed as demonstrated by restriction enzyme analysis (Figure 4.13, lanes 4, 5). 
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Figure 4.13. Cloned R. norvegicus syntaxin 18 DNA ligated into pET28a vector. 1% 
agarose gel. Separation of restriction digests, demonstrating successful ligation of cloned 
rat syntaxin 18 into pET28a (lanes 4, 5). 
The full length rat-pET28a was induced in E. coli BL21 with 1.5 mM IPTG (section 
3.2.1.), however the culture was harvested after 4 hours. The recombinant protein 
unquestionably expressed as a thickened band of the approximate predicted size of 45 
kDa (Figure 4.14). 
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Figure 4.14. 15% SDS PAGE analysis of R. norvegicus full length protein 
expression in pETa28. Protein expression observed in two individual cultures. 
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Full length rat recombinant protein was extracted from the inclusion bodies and was 
resuspended by the 2 M urea wash (Figure 4.15, lanes 4 & 9). 
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Figure 4.15. 15% SDS PAGE analysis ofR. norvegicus recombinant protein isolated in 
2M urea washes. Inclusion bodies in two inductions of rat were extracted; lanes 3 and 9 
demonstrate clearly the recombinant protein is in the 2M urea fraction. Lanes 5 & 9 
were blank however overflow from previous lane occurred. 
The full length recombinant rat protein was expected to elute at pH 4.5; however no 
protein band was observed in the elution fraction (Figure 4.16): 
KQa MW 2M E IU t i0n P h 4 ' 5 
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Figure 4.16. 15% SDS PAGE analysis of R. norvegicus protein is not eluting at pH 4.5. 
The full length recombinant protein is showing in the 2M urea, lane 2; lanes 3, 4 and 5 
are elution fractions where no protein band at the approximate size for full length rat is 
appearing. 
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4.1.10. Ligation, Expression and Purification of Rattus Norvegicus without Trans 
Membrane Domain (Rat-ATMD) in pET28a. 
The carboxy terminal trans membrane domain of the Rat syntaxin 18 was generating a 
protein that was being sequestered in inclusion bodies. Therefore, removing the trans 
membrane domain from the gene was performed to improve the solubility of the 
recombinant protein as described in section 3.2.8 and successful removal is generating 
Rat-ATMD pET28a, demonstrated by Figure 4.17. 
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Figure 4.17. Ligation of R. norvegicus minus the trans-membrane domain into pETa28. 
1% Agarose gel. Illustrates successful ligation of 3 rat-ATMD clones into 
pET28aexpression vector (lanes 3-5). 
BL21 cells were transformed with the Rat-ATMD pET28a vector and were induced 
with 1.5 mM IPTG (section 3.2.1), harvesting cells after four hours. Rat-ATMD 
recombinant protein was successfully induced as indicated by an enriched thickened 
band, at an estimated 40% to background proteins, at the approximate predicted size of 
45 kDa (Figure 4.18). 
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Figure 4.18. 15%SDS PAGE analysis of R. norvegicus-ATMD protein expression after 4 
hours. Arrow indicates Rat-ATMD expression in lanes 3 and 5. 
The Rat-ATMD recombinant protein (Rat-ATMD) was purified under denaturing 
conditions as described previously. Comparison between the supernatant and flow 
through of the Ni-NTA column illustrate that much of the recombinant protein did bind 
to the Ni-NTA resin bed (Figure 4.19, lanes 4 and 5). Rat-ATMD eluted from the column 
at pH 4.5 with 90% relative purity (Figure 4.19, lanes 2 and 3). 
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Figure 4.19. 15% SDS PAGE analysis of R. norvegicus-ATMD protein purification and 
elution. Lanes 2 & 3 elution fractions containing rat-ATMD protein. 
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4.1.11. Renaturation of Rattus norvegicus - ATMD. 
As Rat-ATMD was purified under denaturing conditions with 8M urea, the protein had 
to be refolded in preparation for endonuclease testing. Renaturing requires the protein to 
be subjected to an appropriate aqueous environment to promote electrostatic interactions 
between amino acid groups (Petsko GA., 2004). 
The Rat-ATMD was refolded by sequential dialysis, employing three different dialysis 
buffer systems. Two buffer systems used a stepwise decrease in urea concentration with 
pH adjustment, while the third incorporated a denaturant. The first buffer system 
(Dialysis A), incorporated a gradual increase of pH from 5.0 to 7.4 in the final buffer 
exchange (section 3.3.1.1). The second dialysis buffer system (Dialysis B) began with the 
buffer at pH 7.4 and this pH was maintained throughout the dialysis (section 3.3.1.2). 
The third dialysis buffer exchange (Dialysis C) subjected the recombinant protein to 
guanidine/p-mercaptoethanol to disrupt sulphide bridges followed by a reducing 
environment to allow for sulphide bridge formation (section 3.3.1.3). 
After refolding the Rat-ATMD, all three dialysis protocols were tested for 
endonuclease activity (section 3.3.6) Endonuclease activity was determined by 
comparing cleavage products of the c-myc CRD y32P-RNA of the refolded proteins to the 
observed products of the positive control, a partially purified native 35 kDa nuclease 
from rat liver supplied by T. Barnes (2007) (Figure 4.20, lanes 2 and 3). Results indicated 
activity in the refolding methods which used urea concentration reductions where pH was 
gradually decreased or maintained at 7.4 (Figure 4.20, lanes 4-7 and lanes 8-11), 
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and that protein refolding based on guanidine/p-mercaptoethanol was not suitable as no 
nucleolytic activity was observed (Figure 4.20, lanes 12-15). 
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Figure 4.20. Endonuclease assay for comparison of the three dialysis protocols used to 
refold rat-ATMD. 8% Acryl amide; 7M urea gel. Lane 1: -ve control. Lane 2: 0.4U 35 
kDa nuclease, lane 3: 1U 35kDa nuclease, lanes 4-7: (0.5(ig, 1.0 (ig, 2.0ug, 3.0|ig) of rat-
ATMD in decreasing concentration of urea with increase in pH. Lanes 8-11: (0.5fig, 1.0 
(j,g, 2.0|Lig, 3.0|j,g) of rat-ATMD in decreasing concentration of urea at constant pH 7.4. 
Lanes 12-15: (0.5ug, 1.0 fag, 2.0|j,g, 3.0p.g) of rat-ATMD (0.5|ig-3.0p,g) in guanidine/p-
mercaptoethanol buffer. 
All subsequent endonuclease testing was done using recombinant proteins folded 
using Dialysis A system. 
The re-folded rat-ATMD protein was confirmed to be the recombinant R. norvegicus 
syntaxin 18 by Western blot analysis, probing with anti-syntaxin 18 (Figure 4.21 A, lane 
4). As expected, the positive control and rat-ATMD tested positive for anti-syntaxin 
(Figure 4.21A, lanes 2 and 4), whereas BSA and CRD-BP were negative (Figure 4.21A, 
lanes 5 and 6). After the initial exposure the blot was stripped of all antibodies (section 
3.2.2.9.2) and re-probed with 6X His-tag antibody (Figure 4.2 IB). The results of the blot 
_ ^ 
* * 
9 m 
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identified the same protein band, confirming the presence of a recombinant protein. The 
positive control CRD-BP and human recombinant syntaxin 18 also tested positive for 
anti-6X-His (Figure 4.2IB, lanes 2, 4, 5), whereas BSA (66kDa) is negative as expected 
(Figure 4.2IB, lane 6). 
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Figure 4.21. Western blot of purified R. norvegicus-ATMD protein. Figure A: Probed 
with anti-syntaxin. Figure B stripped then reprobed with anti 6X-His. Size estimates 
from stained blot before block. Lane 1: Rainbow MW marker (Amersham), lane 2: 
positive control, human full length syntaxin 18, 1.0u.g, Lane 3: blank, lane 4: Rat-ATMD 
l.Oug, lane 5: CRD-BP 1.5ug, lane 6: BSA 1.5ug 
An additional Western blot was performed with an anti-RNase A antibody (Figure 4.22), 
which indicated the absence of RNase A in the purified fractions of Rat-ATMD, CRD-BP 
and BSA, however in the positive control, RNase A was present. 
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Figure 4.22: Western blot with anti-RNase A. Lane 1: Rainbow MW marker 
(Amersham), lane 2: RNase A, l.Ojug, lane 3: 35 kDa nuclease 1.0u.g, lane 4: Rat-ATMD, 
l.Ong, lane 5: CRD-BP 1.5 ug, lane 6: BSA 1.5ug 
4.1.12. Rattus norvegicus-ATMD Endonuclease Assay Against c-Myc CRD y P-
RNA. 
Following the establishment of the most favorable dialysis protocol for renaturation of 
Rat-ATMD, the protein was ready to test to observe if indeed R. norvegicus-ATMD does 
have the ability to cleave c-Myc RNA in vitro. 
Two non-nuclease proteins, BSA and CRD-BP were incorporated in the endonuclease 
assay as along with a partially purified native 35 kDa nuclease from rat liver (Barnes 
2007) as negative and positive controls, respectively. Rat-ATMD cleavage/non cleavage 
pattern was compared to cleavage/non cleavage patterns of the 35 kDa nuclease, BSA 
and CRD-BP in order to identify any specific nucleolytic activity. Increasing 
concentrations of all proteins, from 0.5 ug/uL to 5.0 (ig/uL, were used as in indication of 
protein activity (Figure 4.23, lanes 11-18). 
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Figure 4.23: 8% Acrylamide; 7M urea gel analysis of endonuclease assay of R 
norvegicus syntaxin 18. Lane 1: -ve control. Lane 2: 0.4U 35 kDa (+) nuclease. 
Concentrations of proteins loaded indicated. Appears to be endonucleolytic active in 
lanes 14-18. Cleavage products indicated with arrows. 
The Rat-ATMD aliquots appear to have weak nucleolytic activity as cleavage products 
not observed in the controls, (indicated by the arrows) are apparent, suggesting specific 
degradation of the c-myc CRD y32P-RNA (Figure 4.23, lanes 11-18). 
Following the endonuclease assay, the relative purities of BSA, CRD-BP and Rat-
ATMD used were confirmed by Coomassie stained, (Figure 4.24) and silver stained 
(Figure 4.25) SDS PAGE of samples used. As both the Coomassie stained and silver 
stain analysis indicate, there are numerous proteins present in all samples. The Rat-
ATMD purified recombinant syntaxin 18 (Figure 4.24 lanes 2 - 4 and Figure 4.25 lane 2) 
however, does have contaminants that are distinctly different from those in the positive 
controls (Figure 4.24, lanes 5-10 and Figure 4.25, lanes 3, 4). 
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Figure 4.24. Coomassie stained 15% SDS PAGE analysis of R. norvegicus-ATMD (2.0, 
3.0, 5.0 |ig), CRD-BP (2.0, 3.0, 5.0 fig) and BSA (2.0, 3.0, 5.0 fig) proteins used in the 
endonuclease assay. 
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Figure 4.25. Silver stain of R. norvegicus-ATMD - 3.0 ug, CRD-BP - 3.0 ug, BSA- 3.0 
ug proteins used in the endonuclease assay. Silver staining reveals numerous protein 
bands in the tested proteins. 
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A native endonuclease, purified from R. norvegicus liver that cleaved c-Myc mRNA 
within the coding region was tentatively identified as syntaxin 18. Based upon this 
previous research, the objective of this research was to generate, express and test 
recombinant R. norvegicus syntaxin 18 for nucleolytic activity. 
5.1. Expression and Endonucleolytic Testing of Recombinant R. norvegicus 
Syntaxin 18 
The initial purification attempts with the cloned gene in the pHTT7K vector proved to 
be problematic due to inconsistent expression of any proteins. Western blot analysis 
using anti-syntaxin on the recombinant R. norvegicus inductions in E. coli BL 21 
established that the recombinant protein was indeed being expressed (Figure 4.10) 
however the resultant protein failed to adhere to the Ni-NTA resin bed (Figure 4.12). A 
Western blot analysis with an anti 6X-His revealed that the recombinant R. norvegicus 
protein was being expressed without a 6X-His tag, explaining why not only the R. 
norvegicus recombinant protein was not being purified but also M. musculus, X. laevis, 
D. melanogaster and A thaliana recombinant proteins were not able to be purified. 
The R. norvegicus cDNA was subcloned into a high expression vector, pET 28a. 
Expression of the gene in pET28a was visualized as a thickened band on a 15% SDS 
PAGE by Coomassie staining (Figure 4.14, lanes 2, 4) and the recombinant protein was 
confirmed to have a 6X-His tag, (Figure 4.21, lanes 3, 4), however but purification again 
failed with full-length R. norvegicus recombinant syntaxin 18 (Figure 4.16, lanes 3-5). 
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With no 6X-His tagged recombinant protein eluting, the next step was to determine what 
was shielding the 6X-His tag. 
5.2. Purification of Insoluble Recombinant Proteins 
Purification of integral membrane recombinant proteins is difficult (Purifying 
Challenging Proteins Handbook, 2007). Previous studies indicate that detergents used to 
solubulize recombinant proteins from inclusion bodies continue to interact with the 
recombinant protein (le Maire et al, 2000). Furthermore, lipids from the membrane of the 
inclusion body may still be attracted to the hydrophobic portion of the protein therefore 
could possibly shield the 6X His-tag from the Ni-NTA resin bed. In the case of the full 
length R. norvegicus syntaxin 18, the inclusion bodies housing the recombinant protein 
were isolated in 2M urea buffer containing 2% Trion X-100 providing a detergent to 
possibly buffer the recombinant protein's 6X His-tag. In addition, insoluble recombinant 
proteins that are sequestered in inclusion bodies usually form aggregates (Purifying 
Challenging Proteins Handbook, 2007) and the 2M urea may not be a strong enough 
denaturing agent to expose the 6X His-tag. These reasons could explain why no full 
length rat recombinant protein was binding to the Ni-NTA resin bed. The decision was 
made to remove a substantial portion of the trans-membrane domain from R. norvegicus 
at the carboxy-terminus. 
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5.3. Expression and Purification of R. norvegicus Minus the Trans-Membrane 
Domain 
Following ligation of the newly generated R. norvegicus clone without the trans-
membrane domain (RAT-ATMD) into pET28a, the recombinant protein readily 
expressed (Figure 14.18, lanes 3 and 5). Interestingly, the expression oiR. norvegicus 
without its trans-membrane domain appeared to be much greater (Figure 14.18, lanes 3 
and 5) than full-length R. norvegicus (Figure 14.14, lanes 2 and 4). When comparisons 
are made between their expressions, after taking into account that full length was induced 
at a higher cell density, rat-ATMD appears to have greater expression levels. Perhaps this 
occurrence can be explained by the difference between the E. coli directing cellular 
resources into sequestering insoluble recombinant protein into inclusion bodies versus 
soluble recombinant proteins remaining in the cytosol. Further studies would be required 
to support this hypothesis. 
5.4. Endonucleolytic Testing of Rat-ATMD against c-Myc mRNA CRD 
As rat-ATMD syntaxin 18 was purified under denaturing conditions, the recombinant 
protein had to be refolded. To ensure the protein was refolded in a manner to produce a 
functional protein, three dialysis methods were tested by an endonucleolytic assay 
(Figure 4.20). Following establishment of favourable renaturation, the recombinant rat-
ATMD was subjected to testing for nucleolytic ability. The endonucleolytic assay was 
performed using increasing concentrations of rat-ATMD with a portion of c-myc coding 
region determinant RNA as a substrate. One would expect that increasing protein 
concentration would provide an increase in cleavage products and a reduction in substrate 
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providing that an enzyme was present. Analysis of the assay revealed that the negative 
control, increasing concentrations of BSA and CRD-BP, did appear to produce 
endonucleolytic fragments (Figure 4.23, lanes 3-6 and 7-10 respectively) possibly 
indicating a contaminant. At higher concentrations, rat-ATMD fractions do have 
different cleavage products indicated by arrows (Figure 4.23, lanes 13-18) indicative of 
weak endonucleolytic activity. However the reduction of initial mRNA substrate had not 
noticeably decreased as compared to the substantial decrease of the mRNA substrate in 
the positive control, the 0.4U, 35 kDa native nuclease (Figure 4.23, lane 2, lane 18) 
indicating the level of activity is potentially far less in recombinant R. norvegicus 
syntaxin 18. 
Now the question can be addressed - does recombinant R. norvegicus syntaxin 18 
possess endonucleolytic function? The weak endonucleolytic activity could be attributed to 
two possibilities, one being renatured recombinant protein has activity or it is an activity 
from a separate co-purified protein. Although the dialysis procedure used did provide 
nucleolytic activity (Figure 4.20), the question becomes was this activity attributed to the 
co-purified bacterial proteins or was it indeed the recombinant syntaxin 18? Analysis by 
circular dichrosim (CD) sprectroscopy would be advisable, as circular dichrosim spectra 
analysis measures the spectra of polarized light with baseline spectras for protein secondary 
structures including a-helices and P-sheets (Sreerama 2004). Comparing the circular 
dichrosim spectra of the re-folded recombinant syntaxin 18 to native syntaxin 18 would 
indicate the folding process generated a native fold. 
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A second possibility for the weak activity is co-purified bacterial proteins. The 
evidence suggests weak nucleolytic activity at higher concentrations indicated by the 
arrows in Figure 4.23 pointing to distinct cleavage patterns however Coomassie and silver 
stain analysis reveal co-purified bacterial proteins with recombinant rat-ATMD protein 
(Figure 4.24. lanes 2-4, Figure 4.25, lane 2). The positive controls, CRD-BP and BSA 
likewise have additional protein banding (Figure 4.24 lanes 5-10, Figure 4.25 lanes 3, 4). 
Upon close inspection, one can see that the banding pattern is different between 
recombinant rat-ATMD protein and the positive controls. Recombinant rat-ATMD protein 
has faint protein bands in the 20 kDa range (Figure 4.24, lane 4) whereas CRD-BP and 
BSA have more extraneous bands in the 55 kDa range (Figure 4.24. lanes 7, 10). While 
one RNase, RNase A was ruled out by Western blotting (Figure 4.22), additional RNases 
ubiquitous to E. coli in the 20 kDa range are RNase III at 26 kDa and RNase M5 at 20 kDa 
(Condon et al 2002). Potentially this suggests that there is a possibility that a ubiquitous 
bacterial nuclease co-purified in small quantities explaining why nucleolytic activity is only 
apparent at higher protein concentrations (Figure 4,23, lanes 16 - 18). As anti-RNase III 
and anti-RNase M5 were not available, this possibility was not tested. 
If indeed R. norvegicus recombinant syntaxin 18 does demonstrate endonucleolytic 
activity then pin pointing the catalytic domain would be desirable. Concurrent to my 
research, another graduate student was testing H. sapiens recombinant syntaxin 18 protein 
for endonucleolytic activity using the same research protocols as described previously. His 
research provided strong evidence that recombinant H. sapiens syntaxin 18 protein is not 
an endoribonuclease (Bennett 2008) therefore focusing on the amino sequence differences 
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(Figure 2.1) between the two proteins would be the first step in characterization of a 
putative catalytic domain. 
A point of interest is that the bioinformatic analysis showed that the three mammals 
have a predicted RNA binding domain. Perhaps the c-Myc RNA substrate when bound 
to recombinant R. norvegicus syntaxin 18 was positioned in such a manner that a 
cleavage site was exposed that was readily accessible to a nuclease. Possibly this 
exposure caused the weak endonucleolytic activity in the endonucleolytic assay as the 
fragments are distinctly different from the positive control. 
5.5. The Other Eukaryotes 
The second aim of this research was to test other eukaryotic recombinant proteins that 
had sequence homology to R. norvegicus syntaxin 18. M. musculus recombinant 
syntaxin 18 did express (Figure 4.11) however failed to purify. Removal of the trans 
membrane domain of M. musculus recombinant syntaxin 18 and subcloning into a high 
expression vector would assist in M. musculus purification for future testing. D. 
melanogaster and A. thaliana syntaxin-like recombinant genes did express in the 
pHTT7K vector, however the expressed recombinant proteins failed to be purified as they 
lacked a 6X His-tag (Figure 4.7). Subcloning D. melanogaster and A. thaliana syntaxin-
like genes into a new vector would facilitate their purification for future testing. 
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5.5.1 X laevis Recombinant Protein Expression 
X. laevis recombinant gene expression was inconsistent in pHTT7K. It is possible 
could infer was the possibility that there was a point mutation either within the ribosome 
binding site or downstream in the vector that caused a periodic frameshift dependent 
upon where the ribosome bound to the plasmid. The sequences provided by Macrogen 
Inc did not provide sequence information between the ribosomal binding site and the 
inserted gene therefore this reason for the inconsistent expression cannot be confirmed. 
SubcloningX. laevis recombinant gene into a different vector, such as pET28a and 
inducing should provide reliable recombinant protein expression and purification for a 
testable recombinant protein. 
5.5.2. S. cerevisiae Recombinant UFE 1 protein 
Codon bias was considered as the reason for lack of recombinant UFE 1 expression. 
An analysis for codon bias was undertaken for recombinant UFE 1 gene using the 
Graphical Codon Useage Analyzer (Fuhrmann et al 2004). Codon bias for leucine 
(CUA) and arginine (AUA) in the recombinant gene could have been a possibility, 
producing a truncated recombinant protein. Rosetta™ BL 21 competent cells 
(Novagen®), incorporating six tRNA for infrequently used codons in E. coli were 
employed for S. cerevisiae recombinant UFE 1 expression. Recombinant UFE 1 protein 
remained undetected at 42 kDa on a Coomassie stained SDS PAGE. A Western blot 
analysis with anti-6X His confirmed the nonexistence of recombinant UFE 1 (Figure 4.7, 
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lane 6). The reason for no recombinant UFE 1 expression is not clear. One possibility 
could be that the pHTT7K plasmid containing recombinant UFE 1 had a similar type of 
mutation, as discussed previously with X. laevis, thus expression would not be present. 
Again, subcloning UFE 1 into a new vector would answer this question. 
5.6 Conclusions and Future Directions 
This research demonstrated that proteins without a transmembrane domain not only 
express in larger amounts than recombinant proteins with a transmembrane domain, but 
also readily purify. Further investigation in syntaxin 18 evolutionary role is still 
obtainable with M. musculus, X. laevis, D. melanogaster, S. cerevisiae and A. thaliana 
recombinant gene constructs. Removal of the transmembrane domain located at the 
carboxy terminus followed by subcloning into a high expression vector such as pET28a is 
recommended. As sequencing is inexpensive and readily available, sequencing of the 
construct would be advisable before expression to ensure no spontaneous mutation has 
occurred within the gene. Furthermore, one would expect that removal of the 
transmembrane domain would make these recombinant proteins soluble, as with R. 
norvegicus recombinant syntaxin 18, therefore purification procedures under soluble 
conditions could eliminate the need for re-folding. 
The endonucleolytic assay does not entirely prove or disprove the hypothesis that R. 
norvegicus syntaxin 18 is an endonuclease since the purity of the recombinant protein is 
questionable. To clearly determine if R. norvegicus is an endonuclease, the purity would 
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have to be improved by running the recombinant protein over a size exclusion gel 
filtration column or an antibody affinity chromatography column. 
Although this research has shed doubt on the endonucleolytic capabilities of 
recombinant R. norvegicus syntaxin 18, it has provided a valuable tool for others as 
recombinant R. norvegicus syntaxin 18 minus the trans-membrane domain has been 
generated, expressed and purified. This high expression pET28a vector containing the R. 
norvegicus syntaxin 18-ATMD is available for others to investigate the role of syntaxin 
18 in vesicle transport. For example, syntaxin 18 has been recently implicated as a 
necessary transporter of bovine papilloma virus type 1 viral genome to the nucleus of a 
host cell (Laniosz et al 2007). Papillomavirus minor capsid protein L2 has a specific 
binding site for syntaxin 18 (Laniosz et al 2007). This binding is believed to facilitate the 
viral genome journey to the nucleus as mutated L2 does not bind to syntaxin 18 therefore 
the viral genome is prevented from reaching the nucleus (Laniosz et al 2007). Perhaps 
one can look at over expressing soluble syntaxin 18 and see how it interferes with the 
movement of the viral genome to the nucleus. 
R. norvegicus syntaxin 18 does have a predicted mRNA binding domain. With the 
recent findings that syntaxin 18 appears to have a role in phagocytosis (Hatsuzawa et al, 
2006), coupled with function of syntaxin 18 in vesicular transport, a future direction of 
this investigation would be to determine ifR. norvegicus recombinant syntaxin 18 binds 
mRNA by an using a electrophoretic mobility shift assay. RNA binding could provide 
further insight to syntaxin 18's possible role in the processing of mRNA. 
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Protein expression plasmid maps 
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APPENDIX 2 - RECIPES 
Broth and Media 
Table 1. Luria Broth (LB) 
Yeast extract 
Tryptone 
NaCl 
pH to 7.0 
Final Volume 
10g 
5g 
5g 
1L 
Table 2. SOC Media 
Reagents 
Bacto-tryptone 
Yeast extract 
NaCl 
KC1 
MgCl2 
MgS04 
Glucose 
Concentration 
20g/L 
5g/L 
10 mM 
2.5 mM 
2.5 mM 
2.5 mM 
3.6% v/v 
Buffers 
Table 3. Lysis and denaturing lysis buffers 
Lysis Buffer 50mM NaH2P04 
300 mM NaCl 
10 mM imidazole - pH 8.0 
Denaturing 
Lysis Buffer 
100mMNaH2PO4, 
10 mM Tris-Cl 
8MUrea-pH8.0 
Table 4. PCR Buffer (NEB) 
Tris-HCl 20mM, pH 8.8 
KC1 10 mM 
(NH4)2S04 10 mM 
MgSQ4 2mM 
Triton X-100 0.1% 
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Table 5. Qiagen® Plasmid Midi Kit Buffers 
(QIAGEN Plasmid Purification Handbook, 2003). 
SOLUTION 
Resuspension Buffer 
Stored at 4°C 
Lysis Buffer 
Equilibration Buffer 
Wash Buffer 
Elution Buffer 
COMPOSITION 
50 mM Tris-Cl, pH 8.0 
lOmMEDTA 
lOOug/mLRNaseA 
3.0 M potassium acetate 
pH5.5 
750 mM NaCl 
50 mM MOPS, pH 7.0 
15% isopropanol (v/v) 
0.15% Triton® x-100 (v/v) 
1.0 M NaCl 
50 mM MOPS, pH 7.0 
15% isopropanol (v/v) 
1.5 M NaCl 
50 mM Tris-Cl, pH 8.5 
15% isopropanol (v/v) 
Table 6. STET Buffer 
Reagent 
Glucose 
Triton XI00 
EDTA 
Tris, pH 8.0 
Concentration 
8% 
5% 
50 mM 
50 mM 
Table 7. TE Buffer 
Tris-Cl 
EDTA 
100mM,pH7.4 
10mMpH8.0 
Table 8. Tris Running Buffer 
Tris 
glycine 
(electrophoresis grade) 
SDS 
25 mM 
250 mM 
0.1% 
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Table 9. 8M Urea Buffer 
Urea 
NaH2P04 
Tris-Cl 
8M 
0.1 M 
10 mM, pH 8.0 
Table 10. Rat recombinant protein purification in 2M urea buffer 
Buffer B 2 M urea, 100 mM NaH2PQ4, 10 mM Tris-Cl pH 8.0 
Buffer C 2 M urea, 100 mM NaH2PQ4, 10 mM Tris-Cl pH 6.3 
Buffer D 2 M urea, 100 mM NaH2PQ4, 10 mM Tris-Cl pH 5.9 
Buffer E 2 M urea, 100 mM NaH2PQ4, 10 mM Tris-Cl pH 4.5 
Table 11. Rat-ATMD recombinant protein purification 8M urea 
Buffer B 8 M urea, 100 mM NaH2PQ4, 10 mM Tris-Cl pH 8.0 
Buffer C 8 M urea, 100 mM NaH2PQ4, 10 mM Tris-Cl pH 6.3 
Buffer D 8 M urea, 100 mM NaH2PQ4, 10 mM Tris-Cl pH 5.9 
Buffer E 8 M urea, 100 mM NaH2PQ4, 10 mM Tris-Cl pH 4.5 
Table 12. RNA gel elution buffer 
100 mM Tris-Cl pH 7.5 
0.5 M EDTA 
0.5 volume phenol 
0.5 volume chloroform:isoamyl alcohol 49:1 
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Table 13. Western Blot buffers 
Transfer Buffer 
5% Milk Buffer 
0.5% Milk Buffer 
10X TBS 
5.8g tris base 
2.9g glycine 
(electrophoresis grade) 
200 ml methanol 
Up to 1000 Ml MilliQ H20 
5mL10XTBS 
2.5g Skim milk 
Up to 50 Ml MilliQ H20 
50mL10XTBS 
2.5g Skim milk 
Up to 500 Ml MilliQ H20 
80g NaCl 
2gKCl 
30g Tris 
Up to 800 Ml MilliQ H20 
Table 14. Western blot stripping buffer 
100 mM [3-mercaptoethanol 
2% SDS 
62.5 mM Tris-Cl pH 6.8 
APPENDIX 2 - RECIPES 
Loading dyes, Staining and Destaining Solutions 
Table 15. 2X SDS loading dye 
2XSDS 
loading dye 
25 mM Tris-Cl pH 7.4 
20% glycerol v/v 
4% SDS v/v 
0.2% bromophenol blue w/v 
0.1% [3-mercaptoethanol 
Table 16. Urea/phenol loading dye 
9 M urea 
10% phenol v/v 
0.05 mg/mL bromophenol blue (Sigma) 
0.05 mg/mL xylene cyanol (Sigma) 
0.01 EDTA pH 8.0 
Table 17. Coomassie Blue and Destaining solutions 
Coomassie Stain 0.25% Brilliant Blue R w/v 
50% Methanol v/v 
10% Glacial Acetic Acid v/v 
40% Deionized water 
Destaining Solution 50% Methanol v/v 
10% Glacial Acetic Acid v/v 
40% Deionized water 
Table 18. Fixative and silver staining solutions 
Fixative Enhancer 
Solution 
Silver Staining 
Solution 
50% methanol v/v 
10% Glacial Acetic Acid v/v 
10% Fixative Enhancer Concentrate 
(Bio-RAD) v/v 
30% MilliQ H20 v/v 
5.0 mL Silver complex (Bio-RAD) 
5.0 mL Reduction Moderator (Bio-RAD) 
5.0 mL Image Development Reagent (Bio-RAD) 
50 mL Development Accelerator (Bio-RAD) 
35 mL MilliQ H20 
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Figure 3. R. norvegicus forward sequence 
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Figure 4. R. norvegicus reverse sequence 
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Figure 5. M. musculus forward sequence 
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Figure 6. M. musculus reverse sequence 
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APPENDIX 3 - MACROGEN SEQUENCES 
Figure 8. X. laevis reverse sequence 
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Figure 9. D. melanogaster forward sequence 
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Figure 10. D. melanogaster reverse sequence 
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Figure 11. C. elegans forward sequence 
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Figure 12. C. elegans reverse sequence 
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Figure 13. S. cerevisiae forward sequence 
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Figure 14. S. cerevisiae reverse sequence 
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Figure 15. 4^. thaliana forward sequence 
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Figure 16. A. thaliana reverse sequence 
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